David S Cannom, MD
Disclosures: I/we have no financial relationships to report.
CURRICULUM VITAE Name: David S. Cannom Home Address: 19 Eastfield Drive Rolling Hills, California 90274 Tax I.D.: 33-0074181 Birthdate: May 24, 1940 Birth Place: Kansas City, Missouri Current Position: Medical Director of Cardiology Good Samaritan Hospital 1225 Wilshire Boulevard Los Angeles, California 90017 DEGREES & TRAINING: 1958-1962 B.A., DePauw University, Greencastle, Indiana 1962-1963 Yale Divinity School, New Haven, Connecticut 1963-1967 M.D., University of Minnesota Medical School Minneapolis, Minnesota 1967-1968 Intern in Medicine, Yale-New Haven Hospital New Haven, Connecticut 1968-1969 Assistant Resident in Medicine, Yale-New Haven Hospital, New Haven, Connecticut 1971-1973 Postdoctoral Fellow in Cardiology, Stanford University School of Medicine, Stanford, California STAFF POSITIONS: 1969-1970 Special Assistant to the Director National Center for Family Planning Services United States Public Health Service, DHEW Washington, D.C. David S. Cannom, M.D. 1 STAFF POSITIONS (Continued) 1970-1971 Research Associate, Electrophysiology Laboratory (A.N. Damato, M.D.) U.S. Public Health Service, Cardiology Section U.S. Public Health Service Hospital Staten Island, New York 1973-1976 Assistant Professor of Medicine Yale University School of Medicine New Haven, Connecticut Director, Fitkin Coronary Care Unit and Electrophysiology Laboratory, Yale-New Haven Hospital, New Haven, Connecticut 1976- Clinical Professor of Medicine UCLA School of Medicine, Los Angeles 1976- Active Staff Harbor-UCLA Medical Center 1985- Active Staff Hospital of the Good Samaritan Los Angeles, California 2013 Active Staff Cedars-Sinai Heart Institute Los Angeles, California HONORS: 1962-1963 Rockefeller Fellow Yale Divinity School New Haven, Connecticut 1967 Senior Class President University of Minnesota School of Medicine Minneapolis, Minnesota 1981 Distinguished Teaching Award Department of Medicine Harbor-UCLA Medical Center David S. Cannom, M.D. 2 HONORS (Continued) 1992 Distinguished Teaching Award Department of Medicine Harbor-UCLA Medical Center 1993 Distinguished Service Award American Heart Association Greater Los Angeles Affiliate 1997 Recognition for Outstanding Contributions to the Cardiology Training Programs at Harbor-UCLA Medical Center and Good Samaritan Hospital 1998 Heart of Gold Award American Heart Association Greater Los Angeles Affiliate 2001 President' s Award, NASPE Scientific Sessions 2001- Named to US News Media and Castle Connolly’s “America’s Top Doctors” Roster published online at health.usnews.com/top-doctors 2004 Recipient of the Eugene Drake M.D. Award American Heart Association Northeast Affiliate 2005 Recipient of the Mirowski Award at the Heart Rhythm Society Annual Scientific Sessions 2005 Physician of the Year Award Good Samaritan Hospital Medical Staff 2009 Recipient of the Legends Award Los Angeles Biomedical Research Institute Harbor-UCLA Medical Center 2013 Outstanding Support Award European Cardiac Arrhythmia Society (ECAS) 2015 Distinguished Service Award Heart Rhythm Society (HRS) David S. Cannom, M.D. 3 HONORS (Continued) 2016 Distinguished Alumnus Award DePauw University, Greencastle, IN LICENSURE: California SOCIETIES AND APPOINTMENTS: 1966 Alpha Omega Alpha 1972 Diplomate, American Board of Internal Medicine (#38273) 1973- American Federation of Clinical Research 1974-1979 American Heart Association, National Program Committee, Annual Scientific Session Dallas, Texas 1975- Fellow, Council on Clinical Cardiology American Heart Association 1975- Fellow, American College of Cardiology 1976- Fellow, American College of Physicians 1975 Diplomat, Subspecialty of Cardiovascular Dis 1977- Attending, CCU and Electrophysiology Harbor-UCLA Med Ctr, Torrance, California 1979-1980 Chairman, American Heart Association Los Angeles Affiliate Young Investigators Forum Committee 1979-1983 American Heart Association, Los Angeles Affiliate Fall Symposium Committee, (Chairman 1983) 1979-1980 Chairman, Department of Medicine San Pedro Peninsula Hospital, San Pedro, California David S. Cannom, M.D. 4 SOCIETIES AND APPOINTMENTS (Continued) 1980- Heart Rhythm Society, Member formerly North American Society of Pacing and Electrophysiology 1984-1985 Chief of Staff, San Pedro Peninsula Hospital 1983-1985 National Executive Committee of the Council on Clinical Cardiology, American Heart Association Dallas, Texas 1983-1989 Board of Directors, Research and Education Institute, Harbor-UCLA Medical Center Torrance, California 1979-1983 Board of Trustees, San Pedro Peninsula Hospital San Pedro, California 1984-1985 American Heart Association, Los Angeles Affiliate Chairman, Fall Symposium Committee Chairman, Risk Detection Task Force Chairman, Research Committee 1984-1985 Director, Cardiac Catheterization Laboratory San Pedro Peninsula Hospital 1985 to 1998 Member, American Heart Association, Greater Los Angeles Affiliate, Board of Directors 1985-1989 Vice Chairman, Board of Directors Research and Education Institute Harbor-UCLA Medical Center, Torrance, CA 1985- Clinical Professor of Medicine UCLA School of Medicine, Los Angeles, California 1985- Medical Director of Cardiology Hospital of the Good Samaritan, Los Angeles 1986- Steering Committee, Heart Institute Board of Directors, Heart Institute Hospital of the Good Samaritan, Los Angeles David S. Cannom, M.D. 5 SOCIETIES AND APPOINTMENTS (Continued) 1986-1987 American Heart Association, Los Angeles Affiliate Chairman, Research Committee 1986-1988 Chairman, Quality Assurance Committee Hospital of the Good Samaritan, Los Angeles 1989-1990 President, Los Angeles Affiliate American Heart Association 1989-1993 Secretary of the Medical Staff Hospital of the Good Samaritan 1990-1996 Councilor, California Chapter American College of Cardiology 1990-1996 Member, Building/Fund-Raising Committee No American Society Pacing & Electrophysiology 1990-2001 Member, Long-Range Planning Committee No American Society Pacing & Electrophysiology 1992-1995 Member, Los Angeles Emergency Medical Services Commission, Board of Supervisors County of L.A. 1992-2006 Consultant, Medical Advisory Board Guidant-Cardiac Pacemakers, Inc. 1993-1995 National Emergency Cardiac Care Program' s Task Force on the Use of Mass Media in CPR Training American Heart Association 1993-1995 Member, Scientific Board Sudden Arrhythmia Death Foundation 1993-2003 Regional Councilor, Southwest USA No American Society Pacing & Electrophysiology 1993-1999 Member, Publications Committee No American Society Pacing & Electrophysiology David S. Cannom, M.D. 6 SOCIETIES AND APPOINTMENTS (Continued) 1994-1998 Chairman, Membership Development Committee No American Society Pacing & Electrophysiology 1994-1998 Chairman, Coalition for the Prevention of Sudden Cardiac Death 1995-2001 Member, Committee on Health Policy, NASPE 1995-1998 President, Cardiac Arrhythmias: Research & Education (C.A.R.E.) Foundation 1995-2012 Member, Board of Directors, Cardiac Arrhythmias: Research & Education (C.A.R.E.) Foundation 1995-1998 Member, International Program Committee of the National American Heart Association 1997-1998 Governor-Elect for Southern California 2nd Vice President of the California Chapter American College of Cardiology 1998-1999 Governor for Southern California 1st Vice President of the California Chapter American College of Cardiology 1999-2000 Governor for California President of the California Chapter American College of Cardiology 1996-2004 Member, Board of Trustees No American Society Pacing & Electrophysiology 1997-2001 Member, Annual Scientific Session Program Comm No American Society Pacing & Electrophysiology 1997-1998 2nd Vice President and Co-Chair Annual Scientific Session Program Comm No American Society Pacing & Electrophysiology 1997-2002 Member, Budget and Finance Committee No American Society Pacing & Electrophysiology David S. Cannom, M.D. 7 SOCIETIES AND APPOINTMENTS (Continued) 1997-2003 Member, NASPE/European Society of Cardiology Working Groups on Arrhythmias/Pacing (NASPE/ESCWGA/P) Committee, NASPE 1997-2003 Member, Oral History for Cardiac Pacing & EP No American Society Pacing & Electrophysiology 1997-2001 Member, Web Site Policy Executive Committee No American Society Pacing & Electrophysiology 1997-2002 Member, Executive Committee No American Society Pacing & Electrophysiology 1997-1998 Member, Griffith Commission, L.A. Affiliate American Heart Association 1997- Member, Editorial Advisory Board, Editor Chief for ICD Section, Cardiac Electrophysiology Reviews 1997- Member, Editorial Board Journal of Cardiac Arrhythmias Index & Reviews 1997- Member, Editorial Board Pacing and Clinical Electrophysiology 1998- Member, Board of Directors Cardiac Arrhythmia Center 1998-1999 Member, American Heart Association, Western States Affiliate, Board of Directors 1999-2000 Ex-Officio Member, American Heart Association Western States Affiliate, Board of Directors 1998-1999 1st Vice President and Program Chairman Annual Scientific Session Program Comm No American Society Pacing & Electrophysiology 1999-2002 Co-Chair, By-Laws Committee No American Society Pacing & Electrophysiology David S. Cannom, M.D. 8 SOCIETIES AND APPOINTMENTS (Continued) 1999-2001 Member, Development of Position Statement Comm No American Society Pacing & Electrophysiology 1999-2002 Member, Membership Review Committee No American Society Pacing & Electrophysiology 1999-2001 Physician Advisor, CAP Executive Committee No American Society Pacing & Electrophysiology 1999-2000 President-Elect No American Society Pacing & Electrophysiology 1999-2007 Member, Board of Trustees Minnesota Medical Foundation 2000- Chairman, Operation Heart Beat, American Heart Association Western States Affiliate 2000-2001 President No American Society Pacing & Electrophysiology 2000-2001 President, Board of Trustees No American Society Pacing & Electrophysiology 2000-2001 President, Executive Committee No American Society Pacing & Electrophysiology 2001-2002 Member, Executive Committee No American Society Pacing & Electrophysiology 2001-2004 Member, Board of Trustees No American Society Pacing & Electrophysiology 2000-2002 Member, Budget & Finance Committee No American Society Pacing & Electrophysiology 2000-2002 Member, Committee on Health Policy No American Society Pacing & Electrophysiology 2000-2004 Member, Development Committee No American Society Pacing & Electrophysiology David S. Cannom, M.D. 9 SOCIETIES AND APPOINTMENTS (Continued) 2001-2002 Chair, Long-Range Planning Committee No American Society Pacing & Electrophysiology 2001-2002 Chair, NASPE/ESCWGA/P Committee No American Society Pacing & Electrophysiology 2001-2002 Chair, Nominations & Awards Committee No American Society Pacing & Electrophysiology 2001-2002 Member, Web Site Committee No American Society Pacing & Electrophysiology 2002-2004 Member, NASPE 25th Anniversary Task Force No American Society Pacing & Electrophysiology 2002-2003 Chair, Training & Fellowship Committee' s Advanced Training Clinical Fellowship Task Force No American Society Pacing & Electrophysiology 2002-2003 Co-Chair, Revenue Generating Task Force No American Society Pacing & Electrophysiology 2002-2003 Chair, Development Committee No American Society Pacing & Electrophysiology 2002-2003 Member, Governance Committee No American Society Pacing & Electrophysiology 2002-2010 Chair, Presidents Council, NASPE 2004-2013 Member, Editorial Board The Journal of Cardiovascular Electrophysiology 2005- Member, International Advisory Board Journal of Arrhythmias 2004-2005 Secretary, Heart Rhythm Foundation 2005-2007 President, Heart Rhythm Foundation 2007-2011 Chair, Medtronic Physician Advisory Group David S. Cannom, M.D. 10 SOCIETIES AND APPOINTMENTS (Continued) 2008- Member, Board of Trustees Minnesota Medical Foundation 2009- Member, Editorial Board Progress in Cardiovascular Disease 2009- Member, Editorial Board of the Journal of Cardiovascular Pharmacology and Therapeutics 2010- Member, Heart Advisory Board Division of Cardiology University of Minnesota PRINCIPAL INVESTIGATOR: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD), Boston Scientific-funded, 2016-present, PI Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy" , NIH/NHLBI-sponsored, 2014–present, PI. Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). NIH-sponsored, 2007-present, Investigator. The ICD Sports Safety Registry. Sponsored by Boston Scientific, Medtronic, St. Jude, 2007-2015, Co-PI and National Executive Committee Member. Multicenter Registry of Pacemaker, Implantable Cardioverter Defibrillator (ICD) and Lead Failures. Minneapolis Heart Institute-sponsored, 1999-2015, PI MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). Boston Scientific-funded, 2005-2013, Co-PI and National Executive Committee Member. MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). Boston Scientific-funded, 2009-2013, Co-PI and National Executive Committee Member. The Arrhythmogenic Right Ventricular Dysplasia (ARVD) Registry. NIH-funded, 2002- 2009, PI. David S. Cannom, M.D. 11 PUBLICATIONS: 1. Cannom DS: The Development of Medical Education in the United States. Conn Med 33:124-32, 1969. 2. Cannom DS, Goldreyer BN, Damato AN: Atrioventricular Conduction System in Left Bundle-Branch Block With Normal QRS Axis. Circulation 46:129-37, 1972. 3. Cannom DS, Gallagher JJ, Goldreyer BN, Damato AN: Concealed Bundle of His Extrasystoles Simulating Nonconducted Atrial Premature Beats. Am Heart J 83:777-9, 1972. 4. Miller DC, Cannom DS, Fogarty TJ, Schroeder JS, Daily PO, Harrison DC: Saphenous Vein Coronary Artery Bypass in Patients With "Preinfarction Angina." Circulation 47:234- 41, 1973. 5. Cannom, D.S., Graham, A.F., Harrison, D.C.: Electrophysiological Studies in the Denervated Transplanted Human Heart: Response to Atrial Pacing and Atropine. Circ Res 32-268-78, 1973. 6. Cannom, D.S., Harrison, D.C., Schroeder, J.S.: Hemodynamic Observations in Patients With Unstable Angina Pectoris. Am J Cardiol 33:17-22, 1974. 7. Cannom, D.S. and Harrison, D.C.: Detection of Ventricular Arrhythmia in Real-Time With A Portable Analog Computer. Am J Cardiol 33:399-402, 1974. 8. Cannom, D.S., Miller, D.C., Shumway, N.E., Fogarty, T.J., Daily, P.O., Hu, M., Brown, B., Jr., Harrison, D.C.: The Long-term Follow-up of Patients Undergoing Saphenous Vein Bypass Surgery. Circulation 49:77-85, 1974. 9. Cannom, D.S., Hancock, E.W.: A Syndrome of Congenital Cardiomyopathy With Mitral Regurgitation, Complete Heart Block and Atrial Arrhythmia. Am J Med 56:261-8, 1974. 10. Cannom, D.S.: Electrodes: The Ultimate Interface. In: Harrison, D.C. and Miller, H.A. (eds), Biomedical Electrode Technology: Theory and Practice, p. 315, Academic Press Inc. New York and London, 1974. 11. Goodman, D.J., Harrison, D.C., Cannom, D.S.: Atrioventricular Conduction in Patients With Incomplete Endocardial Cushion Defect. Circulation 49:631-7, 1974. 12. Cannom, D.S., Goodman, D.J., Harrison, D.C.: Electrophysiological Studies in Patients With Rate-Related Intermittent Left Bundle-Branch Block. British Heart J 36:653-659, 1974. David S. Cannom, M.D. 12 PUBLICATIONS (Continued) 13. Goodman, D.J., Rossen, R.M., Cannom, D.S., Rider, A.K., Harrison, D.C.: Effect of Digoxin on Atrioventricular Conduction: Studies in Patients With and Without Cardiac Autonomic Innervation. Circulation 51:251-6, 1975. 14. Cannom, D.S., Goldreyer, B.N., Damato, A.N.: A Demonstration of Differential Refractoriness Within a Single Fascicle of the Human Ventricular Specialized Conduction System. Am Heart J 89:779-84, 1975. 15. Cannom, D.S., Rider, A.K., Stinson, E.B., Harrison, D.C.: Electrophysiologic Studies in the Denervated Transplanted Human Heart, II. Response to Norepinephrine, Isoproterenol and Propranolol. Am J Cardiol 36:859-66, 1975. 16. Cannom, D.S., Levy, W., Cohen, L.S.: The Short- and Long-Term Prognosis of Patients With Transmural and Nontransmural Myocardial Infarction. Am J Med 61:452-8, 1976. 17. Pasternak, R.C., Cannom, D.S., Cohen, L.S.: Echocardiographic Diagnosis of a Large Fungal Verruca Attached to Mitral Valve. British Heart J 38:1209-12, 1976. 18. Batsford, W.P., Cannom, D.S., Zaret, B.L.: Relations Between Ventricular Refractoriness and Regional Myocardial Blood Flow After Acute Coronary Occlusion. Am J Cardiol 41:1083-8, 1978. 19. Wyman, M.G., Lalka, D., Hammersmith, L., Cannom, D.S., Goldreyer, B.N.: Multiple Bolus Technique for Lidocaine Administration During the First Hours of an Acute Myocardial Infarction. Am J Cardiol 41:313-17, 1978. 20. Lalka, D., Wyman, M.G., Goldreyer, B.N., Ludden, T.M., Cannom, D.S.: Procainamide Accumulation Kinetics in the Immediate Postmyocardial Infarction Period. J Clinical Pharmacology 18:397-401, 1978. 21. Cannom, D.S., Wyman, M.G., Goldreyer, B.N.: Initial Ventricular Activation in Left- Sided Intraventricular Conduction Defects. Circulation 62:621-31, 1980. 22. Nademanee, K., Hendrickson, J.A., Cannom, D.S., Goldreyer, B.N., Singh, B.N.: Control of Refractory Life-Threatening Ventricular Tachyarrhythmias by Amiodarone. Am Heart J 101:759-68, 1981. 23. Levy, W., Cannom, D.S., Cohen, L.S.: Nontransmural Myocardial Infarction in Perspective. Cardiovascular Review and Reports 2:1285-1294, 1981. David S. Cannom, M.D. 13 PUBLICATIONS (Continued) 24. Goldreyer, B.N., Olive, A.L., Leslie, J., Cannom, D.S., Wyman, M.G.: A New Orthogonal Lead for P Synchronous Pacing. PACE 4:638-44, 1981. 25. Wyman, M.G., Goldreyer, B.N., Cannom, D.S., Ludden, T.M., Lalka, P.: Factors Influencing Procainamide Total Body Clearance in the Immediate Postmyocardial Infarction Period. J Clin Pharmacol 21:20-25, 1981. 26. Goldreyer, B.N., Brueske, R., Knudson, M.B., Cannom, D.S., Wyman, M.G.: Orthogonal Ventricular Electrogram Sensing. PACE 6:761-8, 1983. 27. Goldreyer, B.N., Knudson, M., Cannom, D.S., Wyman, M.G.: Orthogonal Electrogram Sensing. PACE 6:464-9, 1983. 28. Goldreyer, B.N., Goldreyer, B.A., Wyman, M.G., Cannom, D.S.: A Pre-Hospital Surveillance and Intervention System in Coronary Artery Disease. Clin Prog Pacing and Electrophysiol 1:40, 1983. 29. Nademanee, K., Singh, B.N., Cannom, D.S., Weiss, J., Feld, G., Stevenson, W.G.: Control of Sudden Recurrent Arrhythmic Deaths: Role of Amiodarone. Am Heart J 106:895-901, 1983. 30. Weigal, R.J., Cannom, D.S., Wyman, W.G.: The Management of Common Cardiac Arrhythmias. In: Criley, M. and French, W.G. (Eds), Practical Cardiology, New York, John Wiley and Sons, 1983, p. 127. 31. Nademanee, K., Singh, B.N., Hendrickson, J., Intarachot, V., Lopez, B., Feld, G., Cannom, D.S., Weiss, J.L.: Amiodarone in Refractory Life-Threatening Ventricular Arrhythmias. Ann Intern Med 98:577-84, 1983. 32. Cannom, D.S.: Doing the Undoable: Academic Medicine' s Catch 22. Int J Cardiol 4:237- 40, 1983. 33. Cannom, D.S.: Afterword to the book The Healing Heart by Norman Cousins, W.W. Norton and Company, New York, London, 1983, pp 256-264. 34. Wyman, M.G., Slaughter, R.L., Farolino, D.A., Gore, S., Cannom, D.S., Goldreyer, B.N., Lalka, D.: Multiple Bolus Technique for Lidocaine Administration in Acute Ischemic Heart Disease: II. Treatment of Refractory Ventricular Arrhythmias and the Pharmacokinetic Significance of Severe Left Ventricular Failure. JACC 2:764-9, 1983. David S. Cannom, M.D. 14 PUBLICATIONS (Continued) 35. Cannom, D.S., Wyman, M.G., Goldreyer, B.N.: Clinical and Induced Ventricular Tachycardia in a Patient With Myotonic Dystrophy. J Am Coll Cardiol 4:625-8, 1984. 36. DiCarlo, L.A., Jr., Cannom, D.S.: Laboratory Assessment of Tachyarrhythmias. Diagnosis 7:86, 1985. 37. Kruger, S.R., Michaud, J., Cannom, D.S.: Spontaneous Resolution of a Pericardial Cyst. Am Heart J 109:1390-1, 1985. 38. Cannom, D.S., Winkle, R.: Implantation of the Automatic Implantable Cardioverter/Defibrillator. In Cardiovascular Procedures, Tilkian, Ara and Darley, Elaine (Eds), (book chapter), CV Mosby, St. Louis, 1986, p. 314.39. Cannom, D.S., Winkle, R.A.: Implantation of the Automatic Implantable Cardioverter Defibrillator (AICD): Practical Aspects. PACE 9:793-809, 1986. 40. Kelly, P.A., Cannom, D.S., Garan, H., Finkelstein, I., McComb, J.M., Mirabal, G.S., Ilvento, J.P., Ruskin, J.N.: Predictors of Automatic Implantable Cardioverter Defibrillator Discharge For Life-Threatening Ventricular Arrhythmias. Am J Cardiol 62:83-7, 1988. 41. Kelly, P.A., Wallace, S., Tucker, B., Hurvitz, R.J., Ilvento, J.P., Mirabal, G.S., Cannom, D.S.: Postoperative Infection With the Automatic Implantable Cardioverter Defibrillator: Clinical Presentation and Use of the Gallium Scan in Diagnosis. PACE 11:1220-5, 1988. 42. Kelly, P.A., Cannom, D.S., Garan, H., Mirabal, G.S., Harthorne, W.J., Hurvitz, R.J., Vlahakes, G.J., Jacobs, M.L., Ilvento, J.P., Ruskin, J.N.: The Automatic Implantable Cardioverter-Defibrillator: Efficacy, Complications and Survival in Patients With Malignant and Ventricular Arrhythmias. J Am Coll Cardiol 11:1278-86, 1988. 43. Cannom, D.S.: Implantable Defibrillators. Current Opinion in Cardiology 4:39, 1989. 44. Cannom, D.S.: The Automatic Implantable Cardioverter Defibrillator. In Current Management of Arrhythmias, Horowitz, L. (Ed), (book chapter), B.C. Decker, Inc., Philadelphia, PA, 1991, p. 417-423. 45. Winkle, R.A., Cannom, D.S.: The Automatic Implantable Cardioverter-Defibrillator: Current Applications and Future Directions. In New Perspectives in Cardiac Pacing, Barold, S. Serge and Mugica, Jacques (Eds), (book chapter), Futura Publishing Company, Inc., Mount Kisco, NY, 1991, p. 405-425. David S. Cannom, M.D. 15 PUBLICATIONS (Continued) 46. Cannom, D.S.: Coalition for the Prevention of Sudden Cardiac Death. PACE (Part II) 14:890-892, 1991. 47. Cannom, D.S.: Implantable Cardioverter Defibrillator: The Promise and Perils of an Evolving Technology. PACE 15:1-4, 1992. 48. Levy, W., Cannom, D.S., Cohen, L.S.: Classics of the Decade with Author Update 1992: The Nontransmural Myocardial Infarction in Perspective. Cardiovascular Reviews and Reports 13:8-17, 1992. 49. Epstein, A.E., Ellenbogen, K.A., Kirk, K.A., Kay, G.N., Dailey, S.M., Plumb, V.J., Fogoros, R., Maloney, J., Pinski, S., Swirin, S., Cannom, D.S., Guarniari, T., Hummell, J., Chapman, P., Levine, J., Veltri, E., Naccarelli, G., Echt, D.: Clinical Characteristics and Outcome of Patients with High Defibrillation Thresholds. A Multi-Center Study. Circulation 86: 1206-1216, 1992. 50. Cannom, D.S.: A Critical Appraisal of Indications for the Implantable Cardioverter Defibrillator (ICD). Clin Cardiol 15:369-372, 1992. 51. Cannom, D.S.: Current Indications and Contraindications for ICD Implantation. In Implantable Cardioverter Defibrillators, Naccarelli, G.V. and Veltri, E.P. (Eds), (book chapter), Blackwell Scientific Publications Inc., Cambridge, MA, 1992. 52. Meissner, M.D., Lehmann, M.H., Steinman, R.T., Mosteller, R.D., Akhtar, M., Calkins, H.G., Cannom, D.S., Epstein, A.E., Fogoros, R.N., Liem, L.B., Marchlinski, F.E., Myerburg, R.J., Veltri, E.P.: Ventricular Fibrillation in Patients Without Significant Structural Heart Disease: A Multicenter Experience with Implantable Cardioverter- Defibrillator Therapy. J Am Coll Cardiol 21(6):1406-1412, 1993. 53. Cannom, D.S.: ICD: The U.S. Experience. In Cura Intensiva Cardiologica 1993, Caturelli, G. (Ed), (book chapter), MGA s.r.l. Viale G. Mazzini, Roma, 1993. 54. Powell, A.C., Fuchs, T., Finkelstein, D.M., Garan, H., Cannom, D.S., McGovern, B.A., Kelly, E., Vlahakes, G.J., Torchiana, D.F., Ruskin, J.N.: Influence Implantable Cardioverter Defibrillators on the Long-Term Prognosis of Survivors of Out-of-Hospital Cardiac Arrest. Circulation 88:1083-1092, 1993. 55. Bhandari, A.K., Lerman, R., Ehrlich, S., Sager, P., Leon, C., Widerhorn, J., Cannom, D.S.: Electrophysiological Evaluation of Moricizine in Patients with Sustained Ventricular Tachyarrhythmias: Low Efficacy and High Incidence of Proarrhythmia. PACE 16:1853- 1861, 1993. David S. Cannom, M.D. 16 PUBLICATIONS (Continued) 56. Porterfield, J.G., Porterfield, L.M., Smith, L.B., Voshage, L., Martinez, A., and the VENTAK PRx Phase I Investigators: Conversion Rates of Induced Versus Spontaneous Ventricular Tachycardia by a Third Generation Cardioverter Defibrillator. PACE 16 (Part II):170-173, 1993. 57. Gadhoke, A., Cannom, D.S., Estes, N.A.: Indications for the Implantable Cardioverter- Defibrillator. In Implantable Cardioverter-Defibrillators: A Comprehensive Textbook, Estes, N.A., Manolis, A.S., Wang, P.J. (Eds), (book chapter), Marcel Dekker, Inc., New York, NY, 1994. 58. Cannom, D.S.: Postoperative Care of the Implantable Cardioverter-Defibrillator (ICD) Patient. In Implantable Cardioverter-Defibrillators: A Comprehensive Textbook, Estes, N.A., Manolis, A.S., Wang, P.J. (Eds), (book chapter), Marcel Dekker, Inc., New York, NY, 1994. 59. Cannom, D.S.: Internal Cardioverter Defibrillator: Newer Technology and Newer Devices. In Cardiac Arrhythmia: Mechanism, Diagnosis and Management, Podrid, P.J., Kowey, P.R. (Eds), (book chapter), William & Wilkins, Philadelphia, PA, 1995. 60. Kloner, R.A., Przyklenk, K., Shook, T., Matthews, R.V., Burstein, S., Cannom, D.S., Isber, N., Kay, G.: Clinical Aspects of Preconditioning and Implications for the Cardiac Surgeon. J Card Surg 10:369-375, 1995. 61. Cannom, D.S.: ICD - Technology and Clinical Applications. In The Third Edition of the Guide to Cardiology, Kloner, R.A. (Ed), (book chapter), Le Jacq Communications, Inc., Greenwich, CT, 1995. 62. Scheinman, M.M, Levine, J.H., Cannom, D.S, Friehling, T., Kopelman, H.A., Chilson, D.A., Platia, E.V., Wilber, D.J., Kowey, P.R., for the Intravenous Amiodarone Multicenter Investigators Group: Dose-Ranging Study of Intravenous Amiodarone in Patients with Life-Threatening Ventricular Tachyarrhythmias. Circ 92:3154-55, 1995. 63. Cannom, D.S.: Book Review of Radiofrequency Catheter Ablation of Cardiac Arrhythmias: Basic Concepts and Clinical Applications, Huang, S. (Ed), (book), Futura Publishing Company, Armonk, NY, 1994. In Circulation 93:190-191, 1996. 64. Cannom, D.S., Ruggio, J.: Specialty Care at the Crossroads: Electrophysiology in the Managed Care Era. Prog Cardiovasc Dis 38:401-406, 1996. 65. Lerman, R.D., Cannom, D.S.: Implantable Cardioverter Defibrillator Advances. Curr Opin Cardiol 11:16-22, 1996. David S. Cannom, M.D. 17 PUBLICATIONS (Continued) 66. Moss, A.J., Hall, W.J., Cannom, D.S., Daubert, J.P. Higgins S.L., Klein, H., Levine J.H., Saksena, S., Waldo, A.L., Wilber, D., Brown, M.W., Heo, M. and the Other MADIT Investigators: Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia. N Engl J Med 335:1933-1940, 1996. 67. Osswald, W., Trouton, T.G., O' Nunain, S.S., Roelke, M., Powell, A.C., Sosa-Suarez, G.E., McGovern, B.A., Garan, H., Cannom, D.S., Ruskin, J.N.: Impact of the Implantable Cardioverter-Defibrillator on Long-Term Outcome in Survivors of Out-of- Hospital Cardiac Arrest with Idiopathic Dilated Cardiomyopathy. Eur JCPE 6;148-154, 1996. 68. Curtis, A.B., Hallstrom, A.P., Klein, R.C., Nath, S., Pinski, S.L., Epstein, A.E., Wyse, G., Cannom, D.S., Renfroe, E.: Influence of Patient Characteristics in the Selection of Patients for Defibrillator Implantation (the AVID Registry). Antiarrhythmics Versus Implantable Defibrillators. Am J Cardiol 79:1185-1189, 1997. 69. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias. N Engl J Med 337:1576-1583, 1997. 70. Bigger, J.T., for The CABG Patch Trial Investigators: Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias After Coronary Artery Bypass Graft Surgery. N Engl J Med 337:1569-1575, 1997. 71. Curtis, A.B., Cannom, D.S., Bigger, J.T., DiMarco, J.P., Estes, N.A.M., Steinman, R.C., Parides, M.K. for the CABG Patch Trial Investigators: Baseline characteristics of Patients in the Coronary Artery Bypass Graft (CABG) Patch Trial. Am Heart J 134;787- 798, 1997. 72. Cannom, D.S.: Private EP Practice in a Strong HMO Environment. CEPR 2:86-88, 1998. 73. Cannom, D.S.: Care of the High Profile Athlete. In Sudden Cardiac Death in the Athlete, Estes, N.A.M., Wang, P.J. (Eds), (book chapter), Futura Publishing Company, Armonk, New York, 1998. 74. Cannom, D.S.: A Review of the Implantable Cardioverter Defibrillator Trials. Curr Opin Cardiol 13:3-8, 1998. David S. Cannom, M.D. 18 PUBLICATIONS (Continued) 75. Cannom, D.S.: AVID and Beyond: Lessons Learned. J Interven Cardiol 11:217-226, 1998. 76. Bhandari, A.K, Isber, N., Estioko, M., Ziccardi, T., Cannom, D.S., Park, Y., Lerman, R.D., Prejean, C., Sun, G.: Efficacy of Low-Energy T Wave Shocks for Induction of Ventricular Fibrillation in Patients With Implantable Cardioverter Defibrillators. Journal of Electrocardiology 31:31-37, 1998. 77. Kloner, R.A., Kay, G.K., Cannom, D.S., Matta, J.M., Shook, T., Fugelso, P., Jamidar, P., Jacques, D.B., Leeka, A., Munger, C.T.: Carve-Out Concept: A Review and Its Importance to Cardiovascular Medicine. Cardiovascular Reviews and Reports IXX(VII):34-43, 1998. 78. Cannom, D.S.: AVID and Beyond: Lessons Learned. Herzschr Elektrophys 9(suppl 2):9- 19, 1998. 79. Cannom, D.S.: Implantable Cardioverter Defibrillator Trials: What Have We Learned? The Journal of Cardiac Arrhythmias: Index & Reviews 3:3-13, 1998. 80. Cannom, D.S., Section Editor: Implantable Cardioverter Defibrillators. Cardiac Electrophysiology Review 2:243-344, 1998. 81. Cannom, D.S.: Implantable Cardioverter Defibrillators (Editorial). CEPR 2:245, 1998. 82. Lerman, R.D., Cannom, D.S.: Indications for Implantable Cardioverter-Defibrillator Therapy. CEPR 2:246-250, 1998. 83. Isber, N., Cannom, D.S.: Value of Antiarrhythmic Drug Therapy and the Implantable Cardioverter Defibrillator in Prolonging Survival in Patients with Severe Congestive Failure. Herzschr Elektrophys 10;23-29, 1999. 84. Cannom, D.S., Prystowsky E: Management of Ventricular Arrhythmias--Detection, Drugs, and Devices. JAMA 281:172-179, 1999. 85. Anderson, J.L, Hallstrom, A.P, Epstein, A.E., Pinski, S.L., Rosenberg, Y, Nora, M.O., Chilson, D., Cannom, D.S., Moore, R., and the AVID Investigators.: Design and Results of the Antiarrhythmics vs Implantable Defibrillators (AVID) Registry. Circulation 99:1692-1699, 1999. 86. Lerman, R.D., Cannom, D.S.: Sudden Electrical Death. Current Treatment Options in Cardiovascular Medicine 1:91-96, 1999. David S. Cannom, M.D. 19 PUBLICATIONS (Continued) 87. Cannom, D.S., Bauman, J.L, Leman, R., Nappi, J.: Managing Ventricular Arrhythmias. Patient Care, September 15, 1999, p. 152-170. 88. Epstein, A.E., Powell, J., Yao, Q., Ocampo, C., Lancaster, S., Rosenberg, Y., Cannom, D.S., Herre, J.M., Greene, H.L., and the AVID Investigators: In-Hospital Versus Out-of- Hospital Presentation of Life-Threatening Ventricular Arrhythmias Predicts Survival. J Am Coll Cardiol 34:1111-1116, 1999. 89. Moss, A.J., Cannom, D.S., Daubert, J.P, Hall, W.J., Higgins, S.L., Klein, H., Wilber, D., Zareba, W., Brown, M.W., for the MADIT II investigators: Multicenter Autonmatic Defibrillator Implantation Trial II (MADIT II): Design and Clinical Protocol. Ann Noninvas Electrocard 4:83-91, 1999. 90. Cannom, D.S.: Other Primary Prevention Trials--What is Clinically and Economically Necessary? Journal Interventional Cardiac Electrophysiology 4:109-115, 2000. 91. Cannom, D.S.: What Has Been the Impact on Clinical Practice of Recently Published Postevent ICD Trials? In Cardiac Arrhythmias 1999, Vol. 1, Raviele, A., (Ed), (book chapter), Springer-Verlag Italia, Milan, 2000. 92. Abe, H., Bhandari, A.K., Lerman, R., Isber, N., Abdullah, E., Firth, B., Cannom, D.S.: A Low Amplitude His-Bundle Potential Predicts Failure of the Right-Sided Approach for Atrioventricular Junction Ablation. Japanese Circulation Journal 64: 257-261, 2000. 93. Cannom, D.S.: Randomized Clinical Trials of Implantable Cardioverter-Defibrillators. In: Interventional Electrophysiology, Second Edition, Singer, I. (Ed), (book chapter) Lippincott Williams and Wilkins, Philadelphia, PA, 2001. 94. Cannom, D.S., Estes, N.A.M. III: Implantable Cardioverter Defibrillators. In Cardiac Arrhythmias: Mechanisms, Diagnosis, and Management, Second Edition, Podrid, P.J., Kowey, P.R. (Eds), (book chapter) Lippincott Williams & Wilkins, New York, New York, 2001. 95. Cannom, D.S., Marchlinski, F.E.: Electrophysiology Self-Assessment Program (EPSAP). Ventricular Arrhythmias and Sudden Cardiac Death. American College of Cardiology, Bethesda, Maryland, 2000. 96. Cannom, D.S.: Atrial Fibrillation: Non-Pharmacologic Approaches. Am J Cardiol 85:25D-35D, 2000. David S. Cannom, M.D. 20 PUBLICATIONS (Continued) 97. Cannom, D.S., Section Editor: Arrhythmias. Current Treatment Options in Cardiovascular Medicine 2:280-364, 2000. 98. Cannom, D.S.: Matching Cardiac Rhythm Management Technology to Patient Needs: Pacing/Ablation/Implantable Cardioverter Defibrillators. Am J Cardiol 86(suppl):58K- 70K, 2000. 99. Moss, A.J., Fadl, Y., Zareba, W., Cannom, D.S., Hall, W.J., for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Survival Benefit with an Implanted Defibrillator in Relation to Mortality Risk in Chronic Coronary Heart Disease. Am J Cardiol 88:516-520, 2001. 100. Estes, N.A.M. III, Link, M.S., Cannom, D., Nacarelli, G.V., Prsytowsky, E.N., Maron, B.J., Oshansky, B.: NASPE Consensus Statement. Report of the NASPE Policy Conference on Arrhythmias and the Athlete. J Cardiovasc Electrophysiol 12:1208-1219, 2001. 101. Winters, S.L, Packer, D.L, Marchlinski, F.E., Lazzara, R., Cannom, D.S., Breithardt, G.E., Wilber, D., Camm, J.A.: Consensus Statement on Indications, Guidelines for Use, and Recommendations for Follow-Up of Implantable Cardioverter Defibrillators. PACE 24:262-269, 2001. 102. Cannom, D.S.: The Implantable Cardioverter Defibrillator in Its 20th Year (Editorial). CEPR 5:5, 2001. 103. Lerman, R.D., Cannom, D.S.: Indications for Implantable Cardioverter Defibrillator Therapy in Year 2000. CEPR 5:6-14, 2001. 104. Swerdlow, C.D., Cannom, D.S.: ICD Product Reliability: Lessons from Electrical Overstress Failures (Guest Editorial). PACE 24:1043-1045, 2001. 105. Ehlert, F.A., Cannom, D.S., Renfroe, E.G., Greene, L., Ledingham, R., Mitchell, L.B., Anderson, J.L., Halperin, B.D., Herre, J.M., Luceri, R.M., Marinchak, R.A., Steinberg, J.S., and the AVID Investigators. Comparison of Dilated Cardiomyopathy and Coronary Artery Disease in Patients with Life-Threatening Ventricular Arrhythmias: Differences in Presentation and Outcome in the AVID Registry. Am Heart J 142:816-822, 2001. David S. Cannom, M.D. 21 PUBLICATIONS (Continued) 106. Kloner, R.A., Arimie, R.B., Kay, G.L., Cannom, D., Matthews, R., Bhandari, A., Shook, T., Pollick, C., Burstein, S.: Evidence for Stunned Myocardium in Humans: A 2001 Update. Coron Artery Dis 12:349-356, 2001. 107. Fuster, V., Ryden, L.E., Asinger, R.W., Cannom, D.S., Crijns, H.J., Frye, R.L., Halperin, J.L., Kay, G.N., Klein, W.W., Levy, S., McNamara, R.L., Prystowsky, E.N., Wann, L.S., Wyse, D.G. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Developed in Collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104:2118-2150, 2001. 108. Lindsay, B.D., Kutalek, S.P., Cannom, D.S., Hammill, S.C., Naccarelli, G.V. NASPE Task Force on Reprocessing of Electrophysiological Catheters. North American Society of Pacing and Electrophysiology. Reprocessing of Electrophysiology Catheters: Clinical Studies, Regulations, and Recommendations. A Report of the NASPE Task Force on Reprocessing of Electrophysiological Cathers. PACE 24:1297-1305, 2001. 109. Fuster, V., Ryden, L.E., Asinger, R.W., Cannom, D.S., Crijns, H.J., Frye, R.L., Halperin, J.L., Kay, G.N., Klein, W.W., Levy, S., McNamara, R.L., Prystowsky, E.N., Wann, L.S., Wyse, D.G. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. A Report of the Aermican College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 22:1852- 1923, 2001. 110. Fuster, V., Ryden, L.E., Asinger, R.W., Cannom, D.S., Crijns, H.J., Frye, R.L., Halperin, J.L., Kay, G.N., Klein, W.W., Levy, S., McNamara, R.L., Prystowsky, E.N., Wann, L.S., Wyse, D.G. ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation. A Report of the Aermican College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation). Developed in Collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:2114-2130, 2001. David S. Cannom, M.D. 22 PUBLICATIONS (Continued) 111. Cannon, C.P., Battler, A., Brindis, R.G., Cox, J.L., Ellis, S.G., Every, N.R., Flaherty, J.T., Harrington, R.A., Krumholz, H.A., Simoons, M.L., Van De Werf, F.J., Weintraub, W.S., Mitchell, K.R., Morrisson, S.I., Anderson, H.V., Cannom, D.S., Chitwood, W.R., Cigarroa, J.E., Collins-Nakai, R.L., Ellis, S.G., Gibbons, R.J., Grover, F.I., Heidenreich, P.A., Khandheria, B.K., Knoebel, S.B., Krumholz, H.I., Malenka, D.J., Mark, D.B., Mckay, C.R., Passamani, E.R., Radford, M.J., Riner, R.N., Schwartz, J.B., Shaw, R.E., Shemin, R.J., VanFossen, D.B., Verrier, E.D., Watkins, M.W., Phoubandith, D.R., Furnelli, T.: American College of Cardiology Key Data Elements and Definitions for Measuring the Clinical Management and Outcomes of Patients with Acute Coronary syndromes. A Report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). JACC 38:2114- 2130, 2001. 112. Cannom, D.S.: Implantable Cardioverter Defibrillator Trials: What' s New? Current Opinion in Cardiology 17:29-35, 2002. 113. Cannom, D.S.: Prevention of Sudden Death in Different Realities: Can We Reach a Consensus? In Cardiac Arrhythmias 2001, Raviele, A., (Ed), (book chapter), Springer- Verlag Italia, Milan, 2002. 114. Moss, A.J., Zareba, W., Hall, J., Klein, H., Wilber, D.J., Cannom, D.S., Daubert, J.P., Higgins, S.L., Brown, M.W., Andrews, M.L. for the MADIT-II Investigators. Improved Survival Due to Prophylactic Use of an Implanted Defibrillator in Patients with Prior Myocardial Infarction and Reduced Left Ventricular Ejection Fraction. N Engl J Med 346:877-883, 2002. 115. Takahashi, T., Cannom, D.S., Bhandari, A.K., Sakurada, H, Hiraoka, M. High Incidence of Device-Related and Lead-Related Complications in Dual Chamber Implantable Cardioverter Defibrillator Compared to Single-Chamber Implantable Cardioverter Defibrillator. Japanese Circulation Journal (in press), 2002. 116. Hauser, R.G., Cannom, D., Hayes, D.L., Parsonnet, V., Hayes, J., Ratliff III, N., Tyers, G.F., Epstein, A.E., Vlay, .C., Furman, S., Gross, J. Long-Term Structural Failure of Coaxial Polyurethane Implantable Cardioverter Defibrillator Leads. PACE 25:879-882, 2002. 117. Jung, F., Herre, J.M., Wood, M.A., O' Donoghue, S., Cannom, D.S., Windle, J.R., Hilbel, T., Talreja, D.R., Parides, M.K., Bigger, J.T., DiMarco, J.P., the CABG Patch Investigators. Influence of Wall Motion Score on Mortality After Coronary Bypass Surgery in the CABG-Patch Trial. International Journal of Cardiology 82:41-47, 2002. David S. Cannom, M.D. 23 PUBLICATIONS (Continued) 118. Cannom, D.S.: A Review of the SCD-HEFT, COMPANION, and CARE-HF Trials. In New Advances in Heart failure and Atrial Fibrillation--Mediterranean Cardiology Meeting 2003, Gulizia, M. (Ed), (book chapter), Srpinger-Verlag Italia, Milan, 2003. 119. Patejak, M.R., Cannom, D.S.: New Device Indications: Impact on the Individual Electrophysiology (EP) Practitioner in a Predominantly Managed Care Environment. CEPR 7:40-43, 2003. 120. Zimetbaum, P., Ho, K.K., Olshansky, B., Lemery, B. H., Friedman, P.A., Cannom, D.S., Chen, X.H., Josephson, M.E.: Variation in the Utilization of Antiarrhythmic Drugs in Patients with New Onset Atrial Fibrillation. Am J Cardiol 91(1):81-83, 2003. 121. Hauser, R., Hayes, D., Cannom, D., Parsonnet, V., Furman, S., Epstein, A., Vlay, S., Tyers, G.F., Irwin, M., Almquist, A., Song, S., Hayes, J., Kallinen, L. Performance of Pacemaker Pulse Generators and Leads: Results from the International Multicenter Registry. In Clinical Cardiac Pacing and Electrophysiology, Tse, H.F., Lee, K.L.F., Lau, C.P. (Eds), (book chapter), Monduzzi Editore International Proceedings Division, Bologna, Italy 2003. 122. Cannom, D.S., Prystowsky, E.N.: The Evolution of the Implantable Cardioverter Defibrillator. PACE 27:419-430, 2004. 123. Cannom, D.S., Prystowsky, E.N.: The Evolution of the Implantable Cardioverter Defibrillator. J Cardiovasc Electrophysiol 15:1-11, 2004. 124. Kang, Steven, Cannom, David S.: Current Role of Device Therapy to Reduce Sudden Cardiac Death in Heart Failure. Current Heart Failure Reports 1:104-110, 2004. 125. Wyman, M.G., Wyman, R.M., Cannom, D.S., Criley, J.M.: Prevention of Primary Ventricular Fibrillation in Acute Myocardial Infarction with Prophylactic Lidocaine. Am J Cardiol 94:545-551, 2004. 126. Husser, D., Bollmann, A., Kang, S., Girsky, M.J., Lerman, R.D., Cannom, D.S., Bhandari, A.K.: Effectiveness of Catheter Ablation for Coexisting Atrial Fibrillation and Atrial Flutter. Am J Cardiol 94:666-668, 2004. 127. Husser, D., Bollmann, A., Kang, S., Stridh, M, Sornmo, L., Olsson, S.B., Bhandari, A.K., Cannom, D.S.: Determinants and Prognostic Significance of Immediate Atrial Fibrillation Recurrence Following Cardioversion in Patients Undergoing Pulmonary Vein Isolation. Pacing Clin Electrophysiol 28(2):119-125, 2004. David S. Cannom, M.D. 24 PUBLICATIONS (Continued) 128. Dorian, P., Borggrefe, M., Al-Khalidi, H.R., Hohnloser, S.H., Brum, J.M., Tatla, D.S., Brachmann, J., Myerburg, R.J., Cannom, D.S., van der Laan, M., Holroyde, M.J., Singer, I., Pratt, C.M.: Shock Inhibition Evaluation with Azimilide (SHIELD) Investigators: Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator. Circulation 14:3646-54, 2004. 129. Joshi, A.K., Kowey, P.R., Prystowsky, E.N., Benditt, D.G., Cannom, D.S., Pratt, C.M., McNamara, A., Sangrigoli, R.M.: First Experience with a Mobile Cardiac Outpatient Telemetry (MCOT) System for the Diagnosis and Management of Cardiac Arrhythmia. Am J Cardiol 95:878-81, 2005. 130. Wyman, M.G., Wyman, R.M., Criley, J.M., Cannom, D.S.: Primary Ventricular Fibrillation Cannot Be Buried; It Never Died. Am J Cardiol 95:817-18, 2005. 131. Sweeney, Michael O., Schoenfeld, Mark H., Cannom, David S. Rules of Evidence: CMS and Primary Prevention of Sudden Cardiac Death in Systolic Heart Failure. Pacing Clin Electrophysiol 28:81-88, 2005. 132 Pratt, C.P, Dorian, P., Al-Khalidi, H.R., Brum, J.M., Borggrefe, M., Tatla, D.S., Brachmann, J., Myerburg, R.J., Cannom, D.S., Holroyde, M.J., Van der Laan, M., Hohnloser, S.H, on behalf of the SHIELD Investigators: Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) Study: A Novel Method to Assess Antiarrhythmic Drug Effect in Patients With an Implantable Cardioverter-Defibrillator. Am J Cardiol 95:274-276, 2005. 133. Bollmann, A., Husser, D., Cannom, D.S.: Antiarrhythmic Drugs in Patients With Implantable Defibrillators. Am J Cardiovasc Drugs 5(6):371-378, 2005. 134. Cannom, D.S.: Prevention of Sudden Cardiac Death. J Cardiovasc Electrophysiology 16(Sup 1):S21-24, 2005. 135. Cannom, D.S., Mower, M.: Relationship of the Implantable Cardioverter Defibrillator (ICD) and Chronic Resynchronization Therapy: The Perfect Marriage? Annals of Noninvasive Electrophysiology 10(4):24-33, 2005. 136. Moss, A.J., Brown, Mary W., Cannom, D.S., et al: Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT): Design and Clinical Protocol. Ann Noninvasive Electrocardiol 10(4):34-43, 2005. David S. Cannom, M.D. 25 PUBLICATIONS (Continued) 137. Lampert, Rachel, Cannom, David, Olshansky, Brian: Safety of Sports Participation in Patients with Implantable Cardioverter Defibrillators: A Survey of Heart Rhythm Society Members. J Cardiovasc Electrophysiol 17:1-5, 2006. 138. Reynolds, M.D., Shah, J., Essebag, V., Olshansky, B., Friedman, P.A., Hadjis, T., Lemery, R., Bahnson, T.D., Cannom, D.S., Josephson, M.E., Zimetbaum, P.: Patterns and Predictors of Warfarin Use in Patients with New Onset Atrial Fibrillation from the FRACTAL Registry. Am J Cardiol 97(4):538-43, 2006. 139. Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S., ACC/AHA TASK FORCE MEMBERS, Smith, S.C., Jacobs, A.K., Adams, C.D., Angerson, J.L., Antman, E.M., Halperin, J.L., Hunt, S.A., Nishimura, R., Ornato, J.P., Page, R.L., Riegel, B., ESC Committee For Practice Guidelines, Priori, S.G., Blane, J.J., Budaj, A., Camm, A.J., Dean, V., Deckers, J.W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J.L., Zamorano, J.L., ESC Committee For Practice Guidelines. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation-- Executive Summary: A Report of the ACC/AHA Task Force on Practice Guidelines and the ESC Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation); Developed in Collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:700-752, 2006. 140. European Heart Rhythm Association; Heart Rhythm Society; Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S., Smith, S.C., Jacobs, A.K., Adams, C.D., Anderson, J.L., Antman, E.M., Hunt, S.A., Nishimura, R., Ornato, J.P., Page, R.L., Riegel, B., Priori, S.G., Blanc, J.J., Budaj, A., Camm, A.J., Dean, V., Deckers, J.W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Zamorano, J.L.; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation--Executive Summary: A Report of the ACC/AHA Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). J Am Coll Cardiol 48:854-906, 2006. David S. Cannom, M.D. 26 PUBLICATIONS (Continued) 141. Hauser, Robert G., Hayes, David L., Epstein, Andrew E., Cannom, David S., Vlay, Stephen C., Song, Susan L., Tyers, G. Frank.: Multicenter Experience with Failed and Recalled ICD Pulse Generators. Heart Rhythm 3:640-644, 2006. 142. Goldenberg, H., Moss, A.J., Hall, W.J., McNitt, S., Zareba, W., Andrews, M.L., Cannom, D.S., for the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators: Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 113:2810-2817, 2006. 143. Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B. Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S.; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation-- Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Prctice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation. Eur Heart J 27:1979-2030, 2006. 144. Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B. Ellenbogen, K.A., Halperin, J.L., Le Heuzey, J.Y., Kay, G.N., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S.; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation-- Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Prctice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation. Europace 8:651-745, 2006. 145. Husser, D., Stridh, M., Cannom, D.S., Bhandari, A.K., Girsky, M.J., Kang, S., Sornmo, L., Olsson, B., Bollmann, A.: Validation and Clinical Application of Time-Frequency Analysis of Atrial Fibrillation Electrocardiograms. J Cardiovasc Electrophysiol 18: 41-46, 2007. 146. Hauser, R.G., Hayes, D.L., Kallinen, L.M., Cannom, D.S., Epstein, A.E., Almquist, A.K., Song, S.L, Tyers, G.F., Vlay, S.C., Irwin, M.: Clinical Experience with Pacemaker Pulse Generators and Transvenous Leads: An 8-Year Prospective Multicenter Study. Heart Rhythm 4(2):154-60, 2007. David S. Cannom, M.D. 27 PUBLICATIONS (Continued) 147. Kloner, R.A., Cannom, D.S.: Uncertainty on the Use of Aldosterone Antagonists for Primary Therapy for Sudden Cardiac Death in the Setting of Implanted Devices. Circulation 115:2983-2989, 2007. 148. Husser, D., Cannom, D.S., Bhandari, A.K., Stridh, M., Sornmo, L., Olsson, S.B., Bollmann, A.: Electrocardiographic Characteristics of Fibrillatory Waves in New-Onset Atrial Fibrillation. Europace 9:638-42, 2007. 149. Tandri, H., Macedo, R., Calkins, H., Marcus, F., Cannom, D., Scheinman, M., Daubert, J., Estes, M., Wilber, D., Talajic, M., Duff, H., Krahn, A, Sweeney, M., Garan, H., Bluemke, D.A.: Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Role of Magnetic Imaging in Arrhythmogenic Right Ventricular Dysplasia: Insights from the North American Arrhythmogenic Right Ventricular Dysplasia (ARVD/C) Study. Am Heart J 155:147-53, 2008. 150. Cannom, D.S.: History and Current Status of Implantable Cardioverter Defibrillator. In Cardiac Pacing and Defibrillation: Principle and Practice, Lu, Fei and Benditt, D.G. (Eds), (book chapter), People' s Medical Publishing House, Beijing, China, 2008. 151. Daubert, J.P., Zareba, W., Cannom, D.S., McNitt, S., Rosero, S.Z., Wang, P., Schuger, C., Steinberg, J.S., Higgins, S.L., Wilber, D.J., Klein, H., Andrews, M.L., Hall, W.J., Moss, A.J.: MADIT II Investigators: Inappropriate Implantable Cardioverter-Defibrillator Shocks in MADIT II: Frequency, Mechanisms, Predictors, and Survival Impact. J Am Coll Cardiol 51:1357-65, 2008. 152. Lampert, R., Cannom, D.: Sports Participation For Athletes With Implantable Cardioverter-Defibrillators Should Be An Individualized Risk-Benefit Decision. Heart Rhythm 5(6):861-863, 2008. 153. Cannom, D.S., Fisher, J.: The Fidelis Recall: How Much Pressure Can the ICD World Bear? Pacing Clin Electrophysiol 31:1233-1235, 2008. 154. Cannom, D.S., Gidney, B.: Azimilide: Another Effort to Prevent Implantable Cardioverter-Defibrillator Shocks and Their Sequelae (Editorial). J Am Coll Cardiol 52:1084-85, 2008. 155. Gidney, B., Cannom, D.S.: The Role of Electrophysiologic Studies in Dilated Cardiomyopathy: Definitive Results from the DEFINITE Trial (Editorial). Pacing Clin Electrophysiol 32:753-4, 2009 David S. Cannom, M.D. 28 PUBLICATIONS (Continued) 156. Marcus, F.I, Wojciech, Z., Calkins, H., Towbin, J.A., Basso, C., Bluemke, D.A., Estes, N.A.M., Picard, M.H., Sanborn, D., Thiene, G., Wichter, T., Cannom, D., Wilber, D.J., Scheinman, M., Duff, H., Daubert, J., Talajic, M., Krahn, A., Sweeney, M.D., Garan, H., Sakaguchi, S., Lerman, B., Kerr, C., Kron, J., Steinberg, J., Sherrill, D., Gear, K., Brown, M.S., Severski, P., Polonsky, S., McNitt, S.: Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Clinical Presentation and Diagnostic Evaluation: Results from the North American Multidisciplinary Study. Heart Rhythm 6:984-992, 2009. 157. Marcus, G.M., Glidden, D.V., Polonsky, B., Zareba, W., Smith, L.M., Cannom, D.S., Estes, N.A.M., Marcus, F., Scheinman, M.M.: Efficacy of Antiarrhythmic Drugs in Arrhythmogenic Right Ventricular Cardiomyopathy: A Report from the North American ARVC Registry. J Am Coll Cardiol 54(7):609-615, 2009. 158. Fonarow, G.C., Albert, N.M., Cannom, D., Lewis, W.R., Shea, J., Walsh M.N.: Sudden Cardiac Arrest Prevention Pathways and Tools. Crit Pathways in Cardiol 8:79-87, 2009. 159. Moss, A.J., Hall, W.J., Cannom, D.S., Klein, H., Brown, M., Daubert, J.P., Estes, N.A.M., Foster, E., Greenberg, H., Higgins, S.L., Pfeffer, M., Wilber, D., Zareba, W., for the MADIT-CRT Trial Investigators: Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events. N Engl J Med 361:1329-1338, 2009. 160. Giada, F., Biffi, A., Cannom, D.S., Cappato, R., Capucci, A., Corrado, D., Delise, P., Drezner, J.A., El-Sherif, N., Estes, M., Furlanello, F., Heidbachel, H., Inama, G., Lindsay, B.D., Maron, B.J., Maron, M.S., Mont, L., Olshansky, B., Pelliccia, A., Thiene, G., Viskin, S., Zeppilli, P., Natale, A., Raviele, A.: Sports and Arrhythmias: A Report of the International Workshop Venice Arrhythmias 2009. Eur J Cardiovasc Prev Rehabil 17(5):607-12, 2010. 161. Yokokawa, M., Bhandari, A.K.,Tada, H., Suzuki, A., Kawamura, M., Ho, I., Cannom, D.S.: Comparison of the Point-by-Point versus Catheter Dragging Technique for Curative Radiofrequency Ablation of Atrial Fibrillation. Pacing Clin Electrophysiol 34(1):15-22, 2011. 162. Eagle, K.A., Cannom, D.S., Garcia, D.A.: Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice. Am J Med 124(1):4-14, 2011. David S. Cannom, M.D. 29 PUBLICATIONS (Continued) 163. Zadeh, A.A., Cannom, D.S., Macrum, B.L., Ho, I.C.: The Use of Balloon Atrial Septostomy to Facilitate Difficult Transseptal Access in Patients Undergoing Catheter Ablation for Atrial Fibrillation. Journal of Cardiovascular Electrophysiology 22:822-824, 2011. 164. Zareba, W., Klein, H., Cygankiewicz, I., Hall, W.J., McNitt, S., Brown, M.W., Cannom, D., Daubert, J.P, Eldar, M., Gold, M.R., Goldberger, J.J., Goldenberg, I., Lichstein, E., Pitschner, H., Rashtian, M., Solomon, S., Viskin, S., Wang, P., Moss, A.J.: Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 123:1061-1072, 2011. 165. Wann, L.S., Curtis, A.B., January, C.T., Ellenbogen, K.A., Lowe, J.E., Estes, N.A. 3rd, Page, R.L., Ezekowitz, M.D., Slotwiner, D.J., Jackman, W.M., Stevenson, W.G., Tracy, C.M., Fuster, V., Ryden, L.E., Cannom, D.S,, Le Heuzey, J.Y., Crijns, H.J., Lowe, J.E. Olsson, S.B., Prystowsky, E.N., Halperin, J.L., Tamargo, J.L, Kay, G.N., Wann, L.S., Jacobs, A.K., Anderson, J.L., Albert, N., Hochman, J.S., Buller, C.E., Kushner, F.G., Creager, M.A., Ohman, E.M., Ettinger, S.M., Stevenson, W.G., Guyton, R.A., Tarkington, L.G., Halperin, J.L., Yancy, C.W.: 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 57(2):223-42, 2011. 166. Wann, L.S., Curtis, A.B., Ellenbogen, K.A., Estes, N.A. 3rd, Ezekowitz, M.D., Jackman, W.M., January, C.T., Lowe, J.E., Page, R.L., Slotwiner, D.J., Stevenson, W.G., Tracy, C.M., Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Kay, G.N., Le Heuzey, J.Y., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, L.S., Jacobs, A.K., Anderson, J.L., Albert, N., Creager, M.A., Ettinger, S.M., Guyton, R.A., Halperin, J.L., Hochman, J.S., Kushner, F.G., Ohman, E.M., Stevenson, W.G., Yancy, C.W.: 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 8(3):e1-8, 2011. David S. Cannom, M.D. 30 PUBLICATIONS (Continued) 167. Wann, L.S., Curtis, A.B., Ellenbogen, K.A., Estes, N.A. 3rd, Ezekowitz, M.D., Jackman, W.M., January, C.T., Lowe, J.E., Page, R.L., Slotwiner, D.J., Stevenson, W.G., Tracy, C.M., Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., Halperin, J.L., Kay, G.N., Le Heuzey, J.Y., Lowe, J.E., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, L.S., Jacobs, A.K., Anderson, J.L., Albert, N., Creager, M.A., Ettinger, S.M., Guyton, R.A., Halperin, J.L., Hochman, J.S., Kushner, F.G., Ohman, E.M., Stevenson, W.G., Yancy, C.W.: 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 8(3):e1-8, 2011. 168 Wann, L.S., Curtis, A.B., January, C.T., Ellenbogen, K.A., Lowe, J.E., Estes, N.A. 3rd, Page, R.L., Ezekowitz, M.D., Slotwiner, D.J., Jackman, W.M., Stevenson, W.G., Tracy, C.M.; 2006 Writing Committee Members, Fuster, V., Ryden, L.E., Cannom, D.S., Le Heuzey, J.Y., Crijns, H.J., Lowe, J.E., Curtis, A.B., Olsson, S.B., Ellenbogen, K.A., Prystowsky, E.N., Halperin, J.L., Tamargo, J.L., Kay, G.N., Wann, L.S.; ACCF/AHA Task Force Members, Jacobs, A.K., Anderson, J.L., Albert, N., Hochman, J.S., Buller, C.E., Kushner, F.G., Creager, M.A., Ohman, E.M., Ettinger, S.M., Stevenson, W.G., Guyton, R.A., Tarkington, L.G., Halperin, J.L., Yancy, C.W.: 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American heart Association Task Force on Practice Guidelines. Heart Rhythm 8(1):157-76, 2011. 169. Wann, L.S., Curtis, A.B., January, C.T., Ellenbogen, K.A., Lowe, J.E., Estes, N.A. 3rd, Page, R.L., Ezekowitz, M.D., Slotwiner, D.J., Jackman, W.M., Stevenson, W.G., Tracy, C.M.; 2011 Writing Group Members, Fuster, V., Ryden, L.E., Cannom, D.S., Le Heuzey, J.Y., Crijns, H.J., Lowe, J.E., Curtis. A.B., Olsson, S.B., Ellenbogen, K.A., Prystowsky, E.N., Halperin, J.L., Tamargo, J.L., Kay, G.N., Wann, L.S.; 2006 Writing Committee Members, Jacobs, A.K., Anderson, J.L., Albert, N., Hochman, J.S., Buller, C.E., Kushner, F.G., Creager, M.A., Ohman, E.M., Ettinger, S.M., Stevenson, W.G., Guyton, R.A., Tarkington, L.G., Halperin, J.L., Yancy, C.W.; American College of Cardiology Foundation/American Heart Association Task Force: 2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123(10):1144-50, 2011. David S. Cannom, M.D. 31 PUBLICATIONS (Continued) 170. Singh, J., Klein, H.U., Huang, D.T., Reek, S., Kuniss, M., Quesada, A., Barsheshet, A., Cannom, D., Goldenberg, I., McNitt, S., Daubert,, J.P, Zareba, W., Moss, A.J.: Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Trial-Cardiac Resynchronization Therapy (MADIT-CRT) Trial. Circulation 123:1159- 1166, 2011. 171. Hoffmayer, K.S., Machado, O.N., Marcus, G.M., Yang, Y., Johnson, C.J., Ermakov, S., Vittinghoff, E., Pandurangi, U., Calkins, H., Cannom, D., Gear, K.C., Tichnell, C., Park, Y., Zareba, W., Marcus, F.I., Scheinman, M.M.: Electrocardiographic Comparison of Ventricular Arrhythmias in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia. J Am Coll Cardiol 58:831-838, 2011. 172. Penn, J., Goldenberg, I., Moss, A.J., McNitt, S., Zareba, W., Klein, H.U., Cannom, D.S., Solomon, S.D., Barsheshet, A., and Huang, D.T., for the MADIT-CRT Trial Investigators: Improved Outcome with Preventive Cardiac Resynchronization Therapy in the Elderly: A MADIT-CRT Substudy. J Cardiovasc Electrophysiol 22:892-897, 2011. 173. Schwartz, B.G., Kloner, R.A., and Cannom, D.S.: Unusual Substrate Underlying Brugada Syndrome and Early Repolarization Syndrome Revealed in Unusual Circadian and Seasonal Patterns. J Cardiovasc Electrophysiol 23(7):764-5, 2012 174. Schwartz, B.G., French, W.J., Mayeda, G.S., Burstein, S., Economides, C., Bhandari, A.K., Cannom, D.S., Kloner, R.A.: Emotional Stressors Trigger Cardiovascular Events. Int J Clin Pract 66(7):631-639, 2012. 175. Hsu, J.C., Solomon, S.D., Bourgoun, M., McNitt, S., Goldenberg, I., Klein, H., Moss, A.J., Foster, E.; MADIT-CRT Executive Committee: Predictors of Super-Response to Cardiac Resynchronization Therapy and Associated Improvement in Clinical Outcome: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization) Study. J Am Coll Cardiol 59(25):2366-73, 2012. 176. Schuger, C., Daubert, J.P., Brown, M.W., Cannom, D., Estes, N.A., Hall, W.J., Klein, H., Olshansky, B., Power, K.A., Wilber, D., Zareba, W., Moss, A.J.: Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): Background, Rationale, and Clinical Protocol. Ann Noninvasive Electrocardiol 17(3):176- 185, 2012. David S. Cannom, M.D. 32 PUBLICATIONS (Continued) 177. Moss, A.J., Schuger, C., Beck, C., Brown, M.W., Cannom, D.S., Daubert, J.P., Estes, N.A.M., Greenberg, H., Hall, W.J., Huang, D., Kautzner, J., Klein, H., Mcitt, S., Olshansky, B., Shoda, M., Wilber, D., Zareba, W., for the MADIT-RIT Trial Invesigators: Reduction in Inappropriate Therapy and Mortality through ICD Programming. N Engl J Med 367(24):2275-2283, 2012. 178. Brenyo, A., Rao, M., Barsheshet, A., Cannom, D., Quesada, A., McNitt, S., Huang, D., Moss, A., Zareba, W.: QRS Axis and the Benefit of Cardiac Resynchronization Therapy in Patients with Mildly Symptomatic Heart Failure Enrolled in MADIT-CRT. J Cardiovasc Electrophysiol, 24(4):442-448, 2013. 179. Benditt, D.G., Cannom, D.S., Guest Editors: Special Syncope Issue Progress in Cardiovascular Diseases 55(4), 2013. 180. Benditt, D.G., Cannom, D.: Introduction: Syncope Issue (Editorial). Progress in Cardiovascular Diseases 55(4):333, 2013. 181. Cannom, D.S.: History of Syncope in the Cardiac Literature. Progress in Cardiovascular Diseases 55(4):334-338, 2013. 182. Lampert, R., Olshansky, B., Heidbuchel, H., Lawless, C., Saarel, E., Ackerman, M., Calkins, H., Estes, N.A.M., Link, M.S., Maron, B.J., Marcus, F., Scheinman, M., Wilkoff, B.L., Zipes, D.P., Berul, C.I., Cheng, A., Law, I., Loomis, M., Barth, C., Brandt, C., Dziura, J., Li, F., Cannom, D.: Safety of Sports for Athletes with Implantable Cardioverter Defibrillators: Results of a Prospective Multinational Registry. Circulation 127:2021-2030, 2013. 183. Anderson, J.L., Albert, N.M., Bozkurt, B., Brindis, R.G., Curtis, L.lH., DeMets, D., Guyton, R.A., Hochman, J.S., Kovacs, R.J., Ohman, E.M., Pressler, S.J., Selke, F.W., Shen, W.K., Wann, L.S., Curtis, A.B., Ellenbogen, K.A., Estes, N.A., Ezekowitz, M.D., Jackman, W.M., January, C.T., Lowe, J.E., Page, R.L., Slotwiner, D.J., Stevenson, W.G., Tracy, C.M., Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., LeHeuzey, J.Y., Kay, G.N., Olsson, S.B., Prystowsky, E.N., Tamargo, J.L., Wann, S.: Management of Patients with Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations): A Report of the American Colletge of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61(18):1935-1944, 2013. 184. Mower, M., Hall, R., Cannom, D.S., Moss A.J.: Biphasic versus Monophasic Cathodal Ventricular Pacing (Point of View). J Cardiovasc Electrophysiol 24(7)844-845, 2013. David S. Cannom, M.D. 33 PUBLICATIONS (Continued) 185. Miwa, Yosuke; Minamiguchi, Hitoshi; Bhandari, Anil K; Cannom, David S; Ho, Ivan C. “Amiodarone reduces the amount of ablation during catheter ablation for persistent atrial fibrillation.” Europace 16(7):1007-14, 2014 186. Olshansky, Brian; Cannom, David S. “Neither too fast nor too hot: keeping marathoners’ hearts alive during the race.” Journal of the American College of Cardiology 64(5):470- 471, 2014 187. Ruwald, Anne-Christine; Schuger, Claudio; Moss, Arthur J; Kutyifa, Valentina; Olshansky, Brian; Greenberg, Henry; Cannom, David S; et al. “Mortality reduction in relation to ICD programming in MADIT-RIT.” Circulation: Arrhythmia and Electrophysiology 7(5):785-92, 2014 188. Goldenberg, Ilan; Kutyifa, Valentina; Klein, Helmut U; Cannom, David S; Brown, Mary W; et al. “Survival with cardiac-resynchronization therapy in mild heart failure.” New England Journal of Medicine 370(18):1694-1701, 2014 189. Daimee UA; Biton Y; Moss AJ; Zareba W; Cannom D; et al. Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease. Ann Noninvasive Electrocardiol. :10.1111/anec.12404, 2016 PUBLISHED ABSTRACTS: 1. Cannom, D.S., Goldreyer, B.N., Damato, A.N.: The Atrioventricular Conduction System in Left Bundle Branch Block. Am J Cardiol 26:627, 1971. 2. Cannom, D.S., Goldreyer, B.N., Damato, A.N.: Evidence for a "Gate" in the Distal Human Ventricular Specialized Conduction System. Circulation (Supp II) 44:148, 1971 3. Cannom, D.S., Schroeder, J.S., Spivack, A.P., Harrison, D.S.: Experience With Impending Myocardial Infarction. Clin Res 20:170, 1972. 4. Austin, M.A., Cannom, D.S., Polumbo, R.A., Schroeder, J.S., Harrison, D.C.: Real- Time Detection of Ventricular Arrhythmias in Ambulatory Patients. Circulation (Supp II) 46:9, 1972. 5. Cannom, D.S., Harrison, D.C.: Electrophysiological Studies in the Transplanted Human Heart. Circulation (Supp II) 46:117, 1972. 6. Cannom, D.S., Schroeder, J.S., Polumbo, R.A., Harrison, D.C.: Hemodynamic Studies During Impending Myocardial Infarction. Circulation (Supp II) 45-46:136, 1972. David S. Cannom, M.D. 34 PUBLISHED ABSTRACTS (Continued) 7. Harrison, D.C., Cannom, D.S.: A New Miniature Portable Analogue Computer for Detecting Ventricular Arrhythmias. Circulation (Supp II) 45-46:166, 1972. 8. Cannom, D.S., Graham, A.F., Harrison, D.C.: His Bundle Electrogram Studies in the Denervated Transplanted Human Heart. Clin Res 21:194, 1973. 9. Schroeder, J.S., Cannom, D.S., Silverman, J.F., Berndt, T.B., Harrison, D.C.: Hemodynamic and Electrophysiologic Findings in Unstable Angina. Clin Res 21:241, 1973. 10. Cannom, D.S., Hancock, E.W.: A Syndrome of Congenital Cardiomyopathy With Mitral Regurgitation, Complete Heart Block and Atrial Arrhythmia. Am J Cardiol 31:124, 1973. 11. Cannom, D.S., Miller, C.M., Fogarty, T.J., Daily, P.O., Shumway, N.E., Harrison, D.C.: Long-term Follow-up of Patients Undergoing Saphenous Vein Bypass Surgery. Am J Cardiol 31:125, 1973. 12. Cannom, D.S., Schroeder, J.S., Harrison, D.C.: Hemodynamic Observations During Impending Myocardial Infarction. Am J Cardiol 31:125, 1973. 13. Schroeder, J.S., Berndt, T.B., Cannom, D.S., Miller, D.C., Austin, M.A., Harrison, D.C.: Long-term Results of Surgery for Unstable Angina Pectoris. Circulation (Supp IV) 48:216, 1973. 14. Letter to the Editor, Circulation 47:669, 1973. Cannom, D.S., Goldreyer, B.N. 15. Stein, E., Cannom, D.S., Lau, S.H., Schnitzler, R.N., Goldreyer, B.N., Damato, A.N.: Evaluation of First Degree Atrioventricular Block Encountered in the Routine ECG. Presented in Proceedings of the Sixth Joint Meeting of the Clinical Society and Commissioned Officers Association, Galveston, Texas, 1971. 16. Harrison, D.C., Goodman, D.J., Cannom, D.S.: Electrophysiology of the Denervated Transplanted Human Heart. Proceedings of the Seventh World Congress of Cardiology, Buenos Aires, 1974. 17. Cannom, D.S., Goodman, D.J., Harrison, D.C., Cohen, L.S.: Electrophysiologic Studies in Rate Related Left Bundle Branch Block. Circulation (Supp III) 50:218, 1974. 18. Rossen, R.M., Goodman, D.J., Cannom, D.S., Rider, A.K., Harrison, D.C.: Effect of Digoxin on Atrioventricular Conduction: Studies in Patients With and Without Cardiac Autonomic Innervation. Am J Cardiol 35:167, 1975. David S. Cannom, M.D. 35 PUBLISHED ABSTRACTS (Continued) 19. Cannom, D.S.: The Effects of Procainamide in Left Bundle Branch Block. Circulation (Supp II) 51-52:137, 1975. 20. Lee, C.H., Cohen, L.S., Cannom, D.S.: Limitations of Sinoatrial Recovery Time in Assessing Sinus Node Dysfunction. Circulation (Supp II) 51-52:12, 1975. 21. Cohen, L.S., Cannom, D.S., Levy, W.K.: A Comparison of the In-Hospital Course of Transmural and Subendocardial MI. Circulation (Supp II) 51-52:170, 1975. 22. Lalka, D., Wyman, M.G., Goldreyer, B.N., Ludden, T.M., Cannom, D.S., McNay, J.L.: Procainamide Pharmacokinetics In Acute Myocardial Infarction Patients. Clin Res 25:272, 1977. 23. Wyman, M.G., Goldreyer, B.N., Cannom, D.S.: Pharmacokinetics of Intravenous Procainamide in Acute Myocardial Infarction. Circulation (Supp II) 58:102, 1978. 24. Cannom, D.S, Goldreyer, B.N., Wyman, M.G.: Left Bundle Branch Block in 1000 Consecutive Myocardial Infarctions. Clin Res 27:2, 1979. 25. Goldreyer, B.N., Cannom, D.S., Wyman, M.G.: Chronic Atrial Tachycardia. Clin Res 27:4, 1979. 26. Goldreyer, B.N., Randels, B.A., Cannom, D.S., Wyman, M.G.: An Emergency Prehospital Intervention System for Coronary Artery Disease. Circulation (Supp II) 60:45, 1979. 27. Goldreyer, B.N., Randels, B.A., Cannom, D.S., Wyman, M.G.: The Efficacy of a Routine Pre-Hospital Intervention System in Coronary Patients. Circulation (Supp III) 62:124, 1980. 28. Nademanee, K., Hendrickson, J.A., Cannom, D.S., Singh, B.N.: Refractory Life- Threatening Ventricular Arrhythmias: Control By Amiodarone Prophylaxis. Circulation (Supp III) 62:151, 1980. 29. Pieper, J.A., Wyman, M.G., Goldreyer, B.N., Cannom, D.S., Slaughter, R.L., Lalka, D.: Lidocaine Toxicity: Effects of Total Versus Lidocaine Concentrations. Circulation (Supp III) 62:181, 1980. 30. Lalka, D., Slaughter, R.L., Goldreyer, B.N., Cannom, D.S., Halton, J.J., Wyman, M.G.: Lidocaine Pharmacokinetics and Metabolism in Acute Myocardial Infarction Patients. Clin Res 28:239A, 1980. David S. Cannom, M.D. 36 PUBLISHED ABSTRACTS (Continued) 31. Nademanee, K., Cannom, D., Hendrickson, J., Goldreyer, B., Singh, B.: Recurrent Sudden Arrhythmic Cardiac Deaths Prevented by Amiodarone: Efficacy Predictable by the Initial Suppression of Ventricular Tachyarrhythmias. Circulation (Supp IV) 64:36, 1981. 32. Goldreyer, B.N., Olive, A.L., Leslie, J., Cannom, D.S., Wyman, M.G.: P Synchronous Pacing: A New Orthogonal Approach to P Wave Sensing. Am J Cardiol 47:434, 1981. 33. Goldreyer, B.N., Amundsun, D., Olive, A.L., Cannom, D.S., Wyman, M.G.: Capture Verification: A New Orthogonal Sensing System for Ventricular Pacing. Circulation (Supp IV) 64:240, 1981. 34. Goldreyer, B.N., Brueske, R., Knudson, M., Cannom, D.S., Wyman, M.G.: Orthogonal Atrial Electrograms: High Amplitude Discriminate P Wave Sensing. Circulation (Supp II) 66:375, 1982. 35. Goldreyer, B.N., Cannom, D.S., Wyman, M.G.: A Solution to Crosstalk in Dual Chambered Pacing Systems. PACE 6:A44, 1983. 36. Wyman, M.G., Cardinale, M., Goldreyer, B.N., Cannom, D.S.: Primary Ventricular Fibrillation May Be Hazardous to Your Health. Circulation (Supp III) 68:107, 1983. 37. Goldreyer, B.N., Schapland, E., Cannom, D.S., Wyman, M.G.: A New Lead for Improved Atrial Sensing in DDD Pacing. Circulation (Supp III) 68:379, 1983. 38. Goldreyer, B.N., Schapland, E., Wyman, M.G., Cannom, D.S.: Atrial Activation Sequencing in the Recognition of Ventriculoatrial Conduction. Circulation (Supp III) 68:379, 1983. 39. Goldreyer, B.N., Cannom, D.S., Wyman, M.G.: Discriminate Atrial Sensing: To See or Not to See. PACE 7:469, 1984. 40. Goldreyer, B.N., Wyman, M.aG., Cannom, D.S.: Determination of Atrial Stimulation Threshold. JACC 3:581, 1984. 41. Mason, J.W. and the Amiodarone Toxicity Study Group. Circulation 12:272, 1985. 42. Kelly, P.A., Cannom, D.S., Finklestein, D., Garan, H., McComb, J., Ilvento, J.P, Ruskin, J.N.: Predictors of Automatic Implantable Cardioverter Defibrillator (AICD) Discharge. Circulation (Supp IV) 76:310, 1987. David S. Cannom, M.D. 37 PUBLISHED ABSTRACTS (Continued) 43. Brodsky, A.M., Miller, M.M., Cannom, D.S., Ilvento, J.P., Mirabal, G.S., Carillo, R.: Psychosocial Adaptation to the Automatic Implantable Cardioverter Defibrillator. Circulation (Supp II) 78:155, 1988. 44. Tordjman-Fuchs, T., Garan, H., McGovern, B., Cannom, D.S., Kelly, E., Finklestein, D., Vlahakes, G., Ruskin, J.N.: Out-of-Hospital Cardiac Arrest: Improved Long-Term Outcome in Patients with Automatic Implantable Cardioverter Defibrillator (AICD). Circulation (Supp II) 80:121, 1989. 45. Winkle, R.A., Mead, R.H., Fain, E.S., Cannom, D.S., Ilvento, J.P., Marchlinski, F.E., Chapman, P.D., Wetherbee, J.N.: Initial Clinical Experience with an Implantable Tiered Therapy Defibrillator. JACC 15:60, 1990. 46. Bhandari, A., Leon, C., Ilvento, J., Cannom, D.S.: Coronary Revascularization in Patients With Sustained Ventricular Tachycardia or Cardiac Arrest: Effects on Inducibility and Long-Term Followup. JACC 17:93A, 1991. 47. Meissner, M.D., Mosteller, R.D., Steinman, R.T., Akhtar, M., Cannom, D.S., Epstein, Al, Fogoros, R., Liem, L.B., Marchlinski, R., Myerburg, E., Veltri, C., Schuger, M.G., Lehman, M.H.: Cardiac Arrest in Patients Without Significant Structural Heart Disease: A Multicenter Experience With Implantable Cardioverter-Defibrillator Therapy. JACC 17:92A, 1991. 48. Epstein, A., Kay, G.N., Daily, S., Plumb, V., Ellenbogen, K., Thomas, A., Cannom, D., Chapman, P., Echt, D., Fogoros, R., Hummel, J., Levine, J., Maloney, J., Naccarrelli, G., Veltri, E.: Incidence of Antiarrhythmic Drug Use in AICD Patients With High Defibrillation Thresholds. JACC 17:352A, 1991. 49. Herre, J.M., Cannom, D.S., Fogoros, R.N., Horowitz, L.N., Guarnieri, T., Irwin, J.M., Levine, J.H., Maloney, J.D., Myerburg, R.J., Porterfield, J.G., Prystowsky, E.N., Veltri, E.P., Winkle, R.A.: Initial Multicenter Clinical Experience with a Multifunctional Implantable Pacemaker Defibrillator. Circulation (II) 84:128, 1991. 50. Guarnieri, T., Cannom, D.S., Chapman, P.D., Chilson, D.A., Echt, D.S., Epstein, A.E., Furman, S., Greer, G.S., Luceri, R.M., Maloney, J.D., Parsonnet, V., Prystowsky, E.N., Ruskin, J.N., Veltri, E.P., Winkle, R.A.: Multicenter Experience: Transvenous Implantable Cardioverter Defibrillator Lead System. Circ 84:428, 1991. 51. Bhandari, A.K, Ehrlich, S.S., Widerhorn, J., Rahimtoola, S.H., Cannom, D.S.: Electrophysiologic Evaluation of Moricizine in Pts with Sustained Ventricular Tachy- arrhythmia: Low Efficacy & High Incidence Proarrhythmia. JACC 19:386A, 1992. David S. Cannom, M.D. 38 PUBLISHED ABSTRACTS (Continued) 52. Ehrlich, S., for The Endotak Investigator Group: Early Survival and Follow-Up Characteristics of 151 Patients Undergoing Transvenous Cardioverter Defibrillator Lead System Implantation. JACC 19:208A, 1992. 53. Ehrlich, S., for the Endotak Investigator Group: Clinical Predictors of Successful Implant of Transvenous Defibrillator Lead System: The Endotak Investigator Group Experience. JACC 19:365A, 1992. 54. Ehrlich, S.S., Cannom, D.S., Dalen, N.A., Ilvento, J.P., Bhandari, A.K.: Radiofrequency Catheter Ablation For Atrioventricular Nodal Reentry Tachycardia by Retrograde Atrial Mapping During Tachycardia: A New Ablation Technique. PACE (Part II) 15:525, 1992. 55. Itoh, S., Yoshida, I., Sumiyoshi, M., Lerman, R., Buono, G., Ehrlich, S., Bhandari, A., Cannom, D.: Influence of Preceding Failed Nonthoractomy Leads Approach on Epicardial Defibrillation Thresholds. PACE 16:916, 1993. 56. Cannom, D.S.: Implantable Cardioverter Defibrillator Therapy: The Crucial Crossroads. Japanese Journal of Intensive Care Medicine, 1993. 57. Sumiyoshi, M., Itoh, S., Yoshida, I., Ehrlich, S., Bhandari, A., Cannom, D.S.: Successful Implantation of Nonthoracotomy Lead System Without or with Subcutaneous Patch. PACE 16(Part II):1577, 1993. 58. Yoshida, I., Itoh, S., Sumiyoshi, M., Ehrlich, S., Bhandari, A., Cannom, D.S.: Follow- up Conversion Testing of Implantable Cardioverter-Defibrillator With Nonthoracotomy Lead System. PACE 16(Part II):1620, 1993. 59. Bollmann, A., Ehrlich, S., Leon, C., Bhandari, A., Cannom, D.: Transvenous Defibrillator Implant Technique: Lower Morbidity and Complication Rate Utilizing Transvenous Leads Alone Without a Sub-Q Patch. PACE 16:1913, 1993. 60. Osswald, S., Nunain, S.S., Roelke, M., Trouton, T.G., Powell, A.C., Perez, I.E., Sosa- Suarez, G.E., Cannom, D.S., McGovern, B.A., Garan, H., Ruskin, J.N.: Out of Hospital Cardiac Arrest in Patients with Idiopathic Dilated Cardiomyopathy: Improved Survival in Recipients of Implantable Cardioverter Defibrillators. PACE 17(Part II):835, 1994. 61. Mehra, A., Ehrlich, S., Cannom, D., Lerman, R., Buono, G., Firth, B., Bhandari, A.: Radiofrequency Ablation of Primary Atrial Tachycardia and Flutter: The Importance of Single vs. Multiple Morphologies. PACE 17(Part II):843, 1994. David S. Cannom, M.D. 39 PUBLISHED ABSTRACTS (Continued) 62. Bhandari, A., Morrison, E., Parker, K., Lerman, R., Arena, C., Cannom, D.: Intravenous Amiodarone for Recurrent Polymorphic Ventricular Tachycardia and Ventricular Fibrillation Related to Acute Myocardial Infarction or Coronary Artery Bypass Surgery. Circulation 90(Part II): I-545, 1994. 63. Kohno, T., Bhandari, A., Park, Y., Bollmann, A., Lerman, R., Cannom, D.: Cluster Shocks in Patients with Third Generation Implantable Cardioverter Defibrillators: Frequency, Mechanisms, and Clinical Significance. PACE 18(Part II):847, 1995. 64. Bollmann, A., Sun, G., Park, Y., Firth, B., Lerman, R., Shook, T.L., Bhandari, A., Cannom, D.: Hospital Resource Consumption in Patients with a Third Generation ICD During Follow-Up. PACE 18(Part II):945, 1995. 65. Bollmann, A., Schmidt, U., Park, Y., Bhandari, A., Cannom, D.: Wound Complications in Patients with Non-Thoracotomy ICD Lead Systems. Presented at Europace 95, the 7th European Symposium on Cardiac Pacing, June 4-7, 1995, Istanbul. 66. Nishimoto, Y., Firth B., Kloner, R., Leor, J., Lerman, R., Bhandari, A., Cannom, D.: The 1994 Northridge Earthquake Triggered Shocks from Implantable Cardioverter Defibrillators. Circulation 92(Part 8):I-605, 1995. 67. Misumi, K., Matthews, R., Mayeda, G., Sun, G., Burstein, S., Shook, T., Cannom, D.: Benefit of Transluminal Extraction Catheter (TEC) Compared with Conventional Balloon Percutaneous Angioplasty (PTCA) for Stenoses of Aortocoronary Saphenous Vein Grafts (SVG). Japanese Circulation Journal 59:429, 1995. 68. Kim, S.G., Love, J., Rosenberg, Y., Powell, J., and the AVID Investigators: Therapy in the AVID (Antiarrhythmics Versus Implantable Debibrillators) Trial Is Not Significantly Different from Current Clinical Practice. Circulation 92 (Part 8):I-782, 1995. 69. Curtis, A.B., Klein, R., Nath, S., Pinski, S.L., Epstein, A.E., Hallstrom, A., Renfroe, E. for the AVID Investigators: Influence of Patient Characteristics in the Selection of Patients for Defibrillator Implantation: The AVID (Antiarrhythmics Versus Implantable Defibrillators) Registry. Circulation 92(Part 8):I-782, 1995. 70. Moss, A.J., Hall, W.J., Cannom, D.S., Daubert, J.P., Higgins, S.L., Klein, H., Levine, J.H., Saksena, S., Waldo A.L., Wilber, D., Brown, M.W, and Other MADIT Investigators: Multicenter automatic defibrillator implantation trial. Circulation 94 (Part 8):I-567, 1996. David S. Cannom, M.D. 40 PUBLISHED ABSTRACTS (Continued) 71. Curtis, A.B., Bigger, J.T., DiMarco, J.P., Cannom, D.S., for the CABG Patch Investigators: Are epicardial defibrillator patch electrodes proarrhythmic? Circulation 94(Part8):I-567, 1996. 72. Kohata, S., Cannom, D., Bhandari, A., Lerman, R., Isber, N., Estioko, M., Park, Y.: Low Incidence of Lead Related Complications in Cephalic Venous Lead Insertion than Subclavian Approach in Implantable Cardioverter Defibrillator Implant. PACE 20:1093, 1997. 73. Steinberg, J.S., Cannom, D.S., Marinchak, R., et al: Dilated Cardiomyopathy Versus Coronary Artery Disease in Patients with VT/VF: Differences in Presentation and Outcome in the AVID Registry. Circulation 96(8)Suppl:I715, 1997. 74. Spoonitz, H.M., Herre, J.M, Raza, S.T., et al: Effect of ICD Implantation on Surgical Morbidity in the CABG Patch Trial. Circulation 96(8)SupplI:I123, 1997. 75. Jung, F., Herre, J.M., Wood, M.A., O' Donoghue, S., Cannom, DnSn, et al: Influence of Wall Motion Score on Mortality after Coronary Bypass Surgery in the CABG Patch Trial. Circulation 96(8)SupplI:I123, 1997. 76. Beckman, K.J., Klein, R.C., Page, R.L., Love, J.C., Moore, R.T., Kandrac, J., Cannom, D.S., Duff, H.J., Hallstrom, A.: Effect of Antiarrhythmic Therapy on Survival in Patients with Ventricular Tachycardia or Fibrillation in the Antiarrhythmics vs Implantable Defibrillators (AVID) Trial Registry. Circulation 96(8)SupplI:I335, 1997. 77. Friedman, P.L., Yao, Q., Buxton, A.E., et al: Effect of Race on Treatment Selection in Patients with Life-Threatening Ventricular Arrhythmia. Circulation 96(8)SupplI:I719, 1997. 78. Steinberg, J.S., Ehlert, F.A., Cannom, D.S., et al: Dilated Cardiomyopathy vs. Coronary Artery Disease in Patients with VT/VF: Differences in Presentation and Outcome in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Circulation 96(8)Suppl:I-715, 1997. 79. Marx, A., Mirabel, G, Cannom, D.S., Bollman, A.: Learning Needs in Patients with Implantable Defibrillators and Their Family Members. Archives des Maladies du Coeur et des Vaisseaux 91(Special III):157-PW2, 1998. 80. Miyata, A., Suzuki, J., Abdullah, E.E., Lerman, R.D., Bhandari, A.K., Park, Y.M., Cannom, D.S.: Long-Term Complications of Implantable Cardioverter Defibrillator with Epicardial Lead System in 317 Pts. Circulation 98(17)SupplI:I788, 1998. David S. Cannom, M.D. 41 PUBLISHED ABSTRACTS (Continued) 81. Epstein, A.E., Graham-Renfroe, E., Powell J., Kim, C.H., Ocampo, C., Cannom, D.S., Herre, J.M., Friedman, P.I., Yao, Q., Lancaster, S., Rosenberg, Y., and the AVID Investigators. JACC 135:435A, 1998. 82. Takahashi, T., Cannom, D.S., Abdullah, E., Lerman, Robert D., Park, Y., Bishara, M., Girsky, M., Bhandari, A.K.: Dual-Chamber Implantable Cardioverter Defibrillator vs Single-Chamber Implantable Cardioverter Defibrillator: High Incidence of Device and Lead Related Complications in Dual-Chamber Implantable Cardioverter Defibrillator. JACC 35:127A, 2000. 83. Takahashi, T., Bhandari, A.K., Park, Y., Watanuki, M., Abdullah, E., Lerman, R.D., Cannom, D.S.: Impact of LV Dysfunction on the Frequency of Major Complications of Dual Chamber Implantable Cardioverter Defibrillators (ICD). PACE 23:571, 2000. 84. Sonne, K., Pfennig, A., Bhandari, A.K., Lerman, R.D., Abdullah, E., Firth, B., Cannom, D.S.: Dual Chamber Implantable Cardioverter Defibrillator: Is There the Expected Improvement in Reducing the Incidence of Inappropriate Therapy? Circulation 102:II-529, 2000. 85. Buhr, Trina A., Bahri, Rupa, Giese, Chad T., Markowitz, Toby, Zipes, Douglas P., Sutton, Richard, Cannom, David S., Benditt, David G.: Holter Analyses Are Inappropriate for Atrial Fibrillation. JACC 37:140A, 2001. 86. Hauser, R.G., Kalinen, L., Hayes, D.L., Parsonnet, V., Furman, S., Irwin, M.E., Cannom, D.S., Song, S., Epstein, A.E., Vlay, S., Hayes, J., Tyers, F., Gross, J.N.: Longevities of Pacemaker and ICD Pulse Generators. PACE 24:575, 2001. 87. Hauser, R.G., Epstein, A.E., Hayes, D.L., Parsonnet, V., Furman, S., Cannom, D.S., Tyers, F., Vlay, S., Hayes, J., Almquist, A., Gross, J.N., Kalinen, L., Song, S.: Causes and Clinical Circumstances of Transvenous ICD Lead Failure. PACE 24:611, 2001. 88. Hauser, R.G., Hayes, D.L., Parsonnet, V., Furman, S., Kalinen, L., Tyers, F., Irwin, M.E., Cannom, D.S., Song, S., Almquist, A., Hayes, J., Gross, J.N.: Insulation Material Rather than Polarity Influences Pacemaker Lead Failure. PACE 24:641, 2001. 89. Sonne, K., Pfennig, A., Bhandari, A.K., Lerman, R.D., Abdullah, E., Cannom, D.S.: Dual vs. Single Chamber ICDs: Equal Incidence of Inappropriate Discharge in Supraventricular Events Gives Rise to Look Closer. PACE 24:661, 2001. David S. Cannom, M.D. 42 PUBLISHED ABSTRACTS (Continued) 90. Reynolds, M.R., Josephson, M.E., Friedman, P.A., Hadjis, T., Lemery, R., Bahnson, T.D., Cannom, D.S., Zimetbaum, P.: Predictors of Warfarin Use in Atrial Fibrillation: Insights From the FRACTAL Registry. JACC 39:85A, 2002. 91. Hauser RG, Almquiest AK, Hayes JJ, Hayes DL, Furman S, Parsonnet V, Cannom DS, Tyers FO, Epstein AE, Vlay SC, Gross JN. Is High Voltage ICD Lead Longevity Finitie? Results from the Multicenter Registry. PACE 25:554, 2002. 92. Hauser RG, Almquist AK, Parsonnet V, Cannom DS, Hayes DL, Epsgtein AE, Furman S, Vlay SC, Tyers FO, Hayes JJ, Gross JN. Reliability and Longevity of ICD Pulse Generators: Results from the Multicenter Registry. PACE 25:577, 2002. 93. Hauser, R.G., Almquist, A.K., Furman, S., Parsonnet, V., Hayes, D.L., Cannom, D.S., Epstein, A.E., Song, S., Irwin, M.E., Hayes, J.J., Tyers, F.O., Kallinen, L. Pacemaker System Longevity and Reliability: Results from the Multicenter Registry. PACE 26 (Part II):981, 2003. 94. Hauser, R.G., Gornick, C.C., Parsonnet, V., Cannom, D.S., Hayes, D.L., Furman, S., Epstein, A.E., Vlay, S.C., Seibert, K.M., Reek, S., Hayes, J.J., Clark, J., Song, S. ICD system Longevity and Reliability: Results from the Multicenter Registry. PACE 26 (Part II):1013, 2003. 95. Reynolds, M.R., Hadjis, T., Schwartzmann, D.S., Cannom, D.S., Bahnson, T.D., Buxton, A., Olshansky, B., Josephson, J.E., Zimetbaum, P. Age and Amiodarone Use Are Important Determinants of the Need for Permanent Pacing Among New Onset AF Patients. PACE 26 (Part II):1016, 2003. 96. Kowey, P.R., Ajay, J., Prystowsky, E.N., Benditt, D.G., Cannom, D.S., Pratt, C.M., McNamara, A., Sangrigoli, R.M. First Experience with a Mobile Cardiac Outpatient Telemetry System for the Diagnosis and Management of Cardiac Arrhythmias. PACE 26 (Part II);1090, 2003. 97. Hauser, R., Kallinen, L., Hayes, D., Hyberger, L, Cannom, D., Park, Y., Parsonnet, V., Furman, S., Gross, J, Tyers G.F., Clark, J., Vlay, S., Song, S., Hayes, J., Epstein, A., Reek, S., Seibert, K., for the Multicenter Registry Investigators. Performance of Implantable Cardioverter Defibrillator Pulse Generators and Leads: Results from the International Multicenter Registry. PACE 26 (Part II);S52, 2003. David S. Cannom, M.D. 43 PUBLISHED ABSTRACTS (Continued) 98. Hauser, R., Hayes, D., Cannom, D., Parsonnet, V., Furman, S., Tyers, G.F., Irwin, M., Vlay, S., Song, S., Hayes, J., Epstein, A., Reek, S., Kallinen, L., for the Multicenter Registry Investigators. Performance of Pacemaker Pulse Generators and Leads: Results from the International Multicenter Registry. PACE 26 (Part II);S100, 2003. 99. Hauser, Robert G., Irwin, Marleen E., Clark, Jacquie, Hayes, David L., Epstein, Andrew E., Kallinen, Linda, Cannom, David, Vlay, Stephen C, Song, Susan, Hayes, John, Parsonnet, Victor, Tyers, Frank O. Clinical Features and Management of Atrial and Ventricular Pacing Lead Failure: A Multicenter Registry Study. Heart Rhythm 1 (1S);S13, 2004. 100. Hauser, R.G., Hayes, D.L., Epstein, A.E., Vlay, S.C., Cannom, D., Kallinen, L., Irwin, M.E., Gross, J.N., Song, S., Tyers, F.O., Selbert, K., Hayes, J., Parsonnet, V. Performance of Implantable Cardiac Rhythm Management Devices: The Multicenter Registry' s 5 Year Experience. Heart Rhythm 1 (1S); S78, 2004. 101. Hauser, R.G., Epstein, A.E., Gornick, C., Cannom, D., Hayes, D.L., Vlay, S.C., Kallinen, L., Seibert, K., Gross, J.N., Parsonnet, V.. Battery Capacity and Manufacturer Significantly Impact ICD Pulse Generator Longevity: A Multicenter Registry Study. Heart Rhythm 1 (1S); S79, 2004. 102. Lampert, R., Cannom, D.S., Olshansky, B.. Safety of Sports in Patients with Implantable Cardioverter Defibrillators: A Survey of NASPE_Heart Rhythm Society Members. Circulation 110;III-626, 2004. 103. Hauser, Robert G., Kallinen, Linda, Song, Susan L., Hayes, David L., Cannom, David S., Epstein, Andrew E., Vlay, Stephen C., Tyers, Frank O., Irwin, Marleen E., Hayes, John. The Multicenter Registry' s Experience with 4,059 ICD and Pacemaker Pulse Generator and Lead Fractures. Heart Rhythm 2; S1: 2005. 104. Hauser, R.G., Hayes, D.L, Epstein, A.E., Vlay, S.C., Cannom, D.S., Song, S.L. Multicenter Experience with 1,355 Failed and Recalled Implantable Cardioverter Defibrillators. JACC 47 (Supp A);20A, 2006. 105. Hayes, D.L., Hauser, R.G., Kallinen, L., Song, S.L., Vlay, S.C., Tyers, G.F., Irwin, M.E., Cannom, D.S., and Epstein, A.E. The Multicenter Registry' s 7 Year Experience With Pacemaker Pulse Generator and Transvenous Lead Failures. Heart Rhythm 3; S103: 2006. David S. Cannom, M.D. 44 PUBLISHED ABSTRACTS (Continued) 106. Hauser, R.G., Epstein, A.E., Vlay, S.C., Cannom, D.S., Hayes, D.L., Kaillinen, L.M., Almquist, A.K., Song, S.L., Tyers, G.F., Irwin, M. Adverse Clinical Events Associated with Normal Pacemaker Pulse Generator End-of-Service Life Behavior. JACC 49 (Supp A);16A, 2007. 107. Machado, O.N., Yang, Y., Johnson, C.J., Marcus, G.M., Calkins, Hl, Cannom, D.,Gear, K.C., Marcus, F.I., Scheinman, M.M.: Ventricular Tachycardia (VT) or Premature Ventricular Beat (PVC) Analysis in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy and Right Ventricular Outflow Tract Tachycardia. Heart Rhythm 7 (Supp);S219, 2010. 108. Zareba, W., Kutyifa, V., Rosero, S., Tompkins, C., Klein, H., Goldenberg, I., Beck, C., McNitt, S., Schuger, C., Cannom, D., Moss, A.J.: Clinical Significance of Supraventricular Tachyarrhythmias in the 170-199 BPM Range in MADIT-RIT Patients. Heart Rhythm 10 (Supp), S150, 2013. Revised: 09/20/16 David S. Cannom, M.D. 45